Overview, Makes use of, Facet Results, Precautions, Interactions, Dosing and Evaluations

Luchsinger JA, Tang MX, Miller J, et al. Relation of upper folate consumption to decrease threat of Alzheimer illness within the aged. Arch Neurol 2007;64:86-92. View summary.

Ma F, Li Q, Zhou X, et al. Results of folic acid supplementation on cognitive perform and Aß-related biomarkers in gentle cognitive impairment: a randomized managed trial. Eur J Nutr 2019;58(1):345-56. View summary.

Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and threat of colorectal most cancers. Most cancers Res 1997;57:1098-102. View summary.

Mangoni AA, Jackson SH. Homocysteine and heart problems: present proof and future prospects. Am J Med 2002;112:556-65.. View summary.

Manns B, Hyndman E, Burgess E, et al. Oral vitamin B(12) and high-dose folic acid in hemodialysis sufferers with hyper-homocyst(e)inemia. Kidney Int 2001;59:1103-9. View summary.

Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for stopping cardiovascular occasions. Cochrane Database Syst Rev. 2017;8:CD006612. View summary.

Matsubara S, Imai Ok, Murayama Ok, Higashizawa T. Extreme liver dysfunction throughout nausea and vomiting of being pregnant: folic acid complement as a prompt perpetrator. J Obstet Gynaecol. 2012;32(7):701-2. View summary.

Matsui MS, Rozovski SJ. Drug-nutrient interplay. Clin Ther 1982;4:423-40. View summary.

Mayer EL, Jacobsen DW, Robinson Ok. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-27. View summary.

Mayer O, Simon J, Rosolova H, et al. The consequences of folate supplementation on some coagulation parameter and oxidative standing surrogates. Eur J Clin Pharmacol 2002;58:1-5.. View summary.

McKeown-Eyssen G, Holloway C, Jazmaji V, et al. A randomized trial of nutritional vitamins C and E within the prevention of recurrence of colorectal polyps. Most cancers Res 1988;48:4701-5. View summary.

McMahon JA, Inexperienced TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A managed trial of homocysteine reducing and cognitive efficiency. N Engl J Med 2006;354:2764-72. View summary.

McNulty H, Rollins M, Cassidy T, et al. Impact of continued folic acid supplementation past the primary trimester of being pregnant on cognitive efficiency within the little one: a follow-up examine from a randomized managed trial (FASSTT Offspring Trial). BMC Med. 2019 Oct 31;17(1):196. View summary.

Mills JL, Von Kohorn I, Conley MR, et al. Low vitamin B-12 concentrations in sufferers with out anemia: the impact of folic acid fortification of grain. Am J Clin Nutr. 2003 Jun;77(6):1474-7.View summary.

Milne DB, Canfield WK, Mahalko JR, Sandstead HH. Impact of oral folic acid dietary supplements on zinc, copper, and iron absorption and excretion. Am J Clin Nutr 1984;39:535-9. View summary.

Montes LF, Diaz ML, Lajous J, et al. Folic acid and vitamin B12 in vitiligo: a dietary strategy. Cutis 1992;50:39-42. View summary.

Moodley J and Norman RJ. Makes an attempt at dietary alteration of prostaglandin pathways within the administration of pre-eclampsia. Prostaglandins Leukot Essent Fatty Acids 1989;37(3):145-147. View summary.

Mooij PN, Thomas CM, Doesburg WH, Eskes TK. Multivitamin supplementation in oral contraceptive customers. Contraception 1991;44:277-88. View summary.

Morgan SL, Baggott JE, Lee JY, Alarcón GS. Folic acid supplementation prevents poor blood folate ranges and hyperhomocysteinemia throughout longterm, low dose methotrexate remedy for rheumatoid arthritis: implications for heart problems prevention. J Rheumatol 1998;25:441-6. View summary.

Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid throughout methotrexate remedy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:833-41. View summary.

Morgan SL, Baggott JE, Vaughn WH, et al. The impact of folic acid supplementation on the toxicity of low-dose methotrexate in sufferers with rheumatoid arthritis. Arthritis Rheum 1990;33:9-18. View summary.

Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and threat of incident Alzheimer illness. Arch Neurol 2003;60:940-6. View summary.

Morris MC, Evans DA, Bienias JL, et al. Dietary folate and vitamin B12 consumption and cognitive decline amongst community-dwelling older individuals. Arch Neurol 2005;62:641-5. View summary.

Morris MS, Fava M, Jacques PF, et al. Despair and folate standing within the US Inhabitants. Psychother Psychosom 2003;72:80-7.. View summary.

Morrow LE, Grimsley EW. Lengthy-term diuretic remedy in hypertensive sufferers: results on serum homocysteine, vitamin B6, vitamin B12, and purple blood cell folate concentrations. South Med J 1999;92:866-70. View summary.

Mottaghi T, Khorvash F, Maracy M, Bellissimo N, Askari G. Impact of folic acid supplementation on nerve conduction velocity in diabetic polyneuropathy sufferers. Neurol Res 2019;41(4):364-8. View summary.

Muggia FM, Synold TW, Newman EM, et al. Failure of pretreatment with intravenous folic acid to change the cumulative hematologic toxicity of lometrexol. J Natl Most cancers Inst 1996;88:1495-6. View summary.

Naderer O, Nafziger AN, Bertino JS. Results of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and antagonistic reactions. Antimicrob Brokers Chemother 1997;41:2466-70. View summary.

Nardini M, De Stefano R, Iannuccelli M, et al. Remedy of melancholy with L-5-hydroxytryptophan mixed with chlorimipramine, a double-blind examine. Int J Clin Pharmacol Res 1983;3:239-50. View summary.

Navarro-Peran E, Cabezas-Herrera J, Garcia-Canovas F, et al. The antifolate exercise of tea catechins. Most cancers Res 2005;65:2059-64. View summary.

Negrao L, Almeida P, Alcino S, et al. Impact of the mix of uridine nucleotides, folic acid and vitamin B12 on the scientific expression of peripheral neuropathies. Ache Manag 2014;4(3):191-6. View summary.

Nelen WL, Blom HJ, Steegers EA, et al. Homocysteine and folate ranges as threat components for recurrent early being pregnant loss. Obstet Gynecol 2000;95:519-24. View summary.

Ni Y, Du J, Yin X, Lu M. Folate consumption, serum folate, and threat of esophageal most cancers: a scientific evaluate and dose-response meta-analysis. Eur J Most cancers Prev 2019;28(3):173-80. View summary.

Nunn PP, Allistone JC. Resistance to trimethoprim-sulfamethoxazole within the remedy of Pneumocystis carinii pneumonia. Implication of folinic acid. Chest 1984;86:149-50. View summary.

O’Keefe SJ, Ogden J, Dicker J. Enteral and parenteral branched chain amino acid-supplemented dietary assist in sufferers with encephalopathy attributable to alcoholic liver illness. JPEN J Parenter Enteral Nutr 1987;11:447-53. View summary.

Oakley GP, Mandel JS. Folic acid fortification stays an pressing well being precedence. Br Med J 2004;329:1376. View summary.

Ogunmekan AO, Hwang PA. A randomized, double-blind, placebo-controlled, scientific trial of D-alpha-tocopheryl acetate (vitamin E), as add-on remedy, for epilepsy in kids. Epilepsia 1989;30:84-9. View summary.

Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, et al. Lengthy-term results of folic acid and vitamin-B12 supplementation on fracture threat and heart problems: Prolonged follow-up of the B-PROOF trial. Clin Nutr. 2020:S0261-5614(20)30398-8. View summary.

Olsen SF, Sorensen JD, Secher NJ, et al. Randomised managed trial of impact of fish-oil supplementation on being pregnant period. Lancet 1992;339:1003-7. View summary.

Opinion of the Scientific Panel on Meals Components, Flavourings, Processing Aids and Supplies in Contact with Meals on a request from the Fee associated to calcium L-methylfolate. EFSA J 2004;135:1-20. Obtainable at: (Accessed 18 March 10).

Ortega RM, Manas LR, Andres P, et al. Practical and psychic deterioration in aged individuals could also be aggravated by folate deficiency. J Nutr 1996;126:1992-9. View summary.

Ortiz Z, Shea B, Suarez Almazor M, et al. Folic acid and folinic acid for lowering unintended effects in sufferers receiving methotrexate for rheumatoid arthritis (Cochrane Evaluate). Cochrane Database Syst Rev 2000;2:CD000951. View summary.

Ortiz Z, Shea B, Suarez-Almazor ME, et al. The efficacy of folic acid and folinic acid in lowering methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized managed trials. J Rheumatol 1998;25:36-43. View summary.

Pack AR, Thomson ME. Results of topical and systemic folic acid supplementation on gingivitis in being pregnant. J Clin Periodontol 1980;7:402-14. View summary.

Passeri M, Cucinotta D, Abate G, et al. Oral 5′-methyltetrahydrofolic acid in senile natural psychological problems with melancholy: outcomes of a double-blind multicenter examine. Getting old (Milano) 1993;5:63-71.. View summary.

Pelliniemi TT, Kasanen A, Sundquist H. Lack of haematological unintended effects throughout prophylactic use of trimethoprim over 4 years. Curr Ther Res 1983;34:436-40.

Peña-Rosas J. P., Viteri, F. E. Results and security of preventive oral iron or iron+folic acid supplementation for girls throughout being pregnant. Cochrane Database Syst Rev 2009;(4):CD004736. View summary.

Prasad AS, Lei KY, Moghissi KS, et al. Impact of oral contraceptives on vitamins. III. Nutritional vitamins B6, B12 and folic acid. Am J Obstet Gynecol 1976;125:1063-9. View summary.

PremesisRx. Pharmacist’s Letter / Prescriber’s Letter 1999:15(12);151206.

Prinz-Langenohl R, Brämswig S, Tobolski O, et al. [6S]-5-methyltetrahydrofolate will increase plasma folate extra successfully than folic acid in girls with the homozygous or wild-type 677C–>T polymorphism of methylenetetrahydrofolate reductase. Br J Pharmacol. 2009;158(8):2014-21. View summary.

Prouse PJ, Shawe D, Gumpel JM. Macrocytic anemia in sufferers handled with sulfasalazine for rheumatoid arthritis. BMJ 1986;293:1407. View summary.

Pullin CH, Ashfield-Watt PA, Burr ML, et al. Optimization of dietary folate or low-dose folic acid dietary supplements decrease homocysteine however don’t improve endothelial perform in wholesome adults, regardless of the methylenetetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 2001;38:1799-805.. View summary.

Absolon, M. J. and Brown, C. A. Acetylcysteine in kerato-conjunctivitis sicca. Br J Ophthalmol. 1968;52(4):310-316. View summary.

Adabag, A. S., Ishani, A., Koneswaran, S., Johnson, D. J., Kelly, R. F., Ward, H. B., McFalls, E. O., Bloomfield, H. E., and Chandrashekhar, Y. Utility of N-acetylcysteine to forestall acute kidney damage after cardiac surgical procedure: a randomized managed trial. Am Coronary heart J 2008;155(6):1143-1149. View summary.

Agarwal, A., Munoz-Najar, U., Klueh, U., Shih, S. C., and Claffey, Ok. P. N-acetyl-cysteine promotes angiostatin manufacturing and vascular collapse in an orthotopic mannequin of breast most cancers. Am.J.Pathol. 2004;164(5):1683-1696. View summary.

Agrawal, M., Wodlinger, A. M., Huggins, C. E., Tudor, G. E., Pieper, J. A., O’Reilly, Ok. P., Denu-Ciocca, C. J., Stouffer, G. A., and Ohman, E. M. Impact of Nacetylcysteine on serum creatinine focus in sufferers with continual renal insufficiency who’re present process coronary

Ahola, T., Lapatto, R., Raivio, Ok. O., Selander, B., Stigson, L., Jonsson, B., Jonsbo, F., Esberg, G., Stovring, S., Kjartansson, S., Stiris, T., Lossius, Ok., Virkola, Ok., and Fellman, V. N-acetylcysteine doesn’t stop bronchopulmonary dysplasia in immature infants: a randomized managed trial. J Pediatr 2003;143(6):713-719. View summary.

Akerlund, B., Jarstrand, C., Lindeke, B., Sonnerborg, A., Akerblad, A. C., and Rasool, O. Impact of N-acetylcysteine(NAC) remedy on HIV-1 an infection: a double-blind placebo-controlled trial. Eur.J Clin Pharmacol 1996;50(6):457-461. View summary.

Akerlund, B., Tynell, E., Bratt, G., Bielenstein, M., and Lidman, C. N-acetylcysteine remedy and the chance of poisonous reactions to trimethoprim-sulphamethoxazole in main Pneumocystis carinii prophylaxis in HIV-infected sufferers. J Infect. 1997;35(2):143-147. View summary.

Al-Ghonaim, M. and Pannu, N. Prevention and remedy of contrast-induced nephropathy. Tech.Vasc.Interv.Radiol. 2006;9(2):42-49. View summary.

Allaqaband, S., Tumuluri, R., Malik, A. M., Gupta, A., Volkert, P., Shalev, Y., and Bajwa, T. Ok. Potential randomized examine of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter.Cardiovasc.Interv. 2002;57(3):279-283. View summary.

Alsalim, W. and Fadel, M. In direction of proof primarily based emergency drugs: greatest BETs from the Manchester Royal Infirmary. Oral methionine in contrast with intravenous n-acetyl cysteine for paracetamol overdose. Emerg.Med.J. 2003;20(4):366-367. View summary.

Amin, A. F., Shaaban, O. M., and Bediawy, M. A. N-acetyl cysteine for remedy of recurrent unexplained being pregnant loss. Reprod.Biomed.On-line. 2008;17(5):722-726. View summary.

Andreana, A., Zampino, R., Tonziello, A., Adinolfi, L. E., Utili, R., and Ruggiero, G. Remedy with N-acetylcysteine (NAC) or ofloxacin (OFLO) as adjunct to INFN failed to attain response in continual hepatitis C sufferers non responding to IFN alone: a part II examine. Hepatology 1997;26:218.

Aylward, M., Maddock, J., and Dewland, P. Scientific analysis of acetylcysteine within the remedy of sufferers with continual obstructive bronchitis: a balanced double-blind trial with placebo management. Eur.J Respir.Dis.Suppl 1980;111:81-89. View summary.

Ayonrinde, O. T., Phelps, G. J., Hurley, J. C., and Ayonrinde, O. A. Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year expertise. Intern Med J 2005;35(11):655-660. View summary.

Azmus, A. D., Gottschall, C., Manica, A., Manica, J., Duro, Ok., Frey, M., Bulcao, L., and Lima, C. Effectiveness of acetylcysteine in prevention of distinction nephropathy. J Invasive.Cardiol. 2005;17(2):80-84. View summary.

Badawy, A., Baker El, Nashar A., and El, Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation within the administration of unexplained infertility: a randomized double-blind managed trial. Fertil.Steril. 2006;86(3):647-650. View summary.

Badawy, A., State, O., and Abdelgawad, S. N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet.Gynecol.Scand 2007;86(2):218-222. View summary.

Baker, C. S., Wragg, A., Kumar, S., De, Palma R., Baker, L. R., and Knight, C. J. A fast protocol for the prevention of contrast-induced renal dysfunction: the RAPPID examine. J Am Coll.Cardiol. 6-18-2003;41(12):2114-2118. View summary.

Baker, C. S., Wragg, A., Kumar, S., De, Palma R., Baker, L. R., and Knight, C. J. A fast protocol for the prevention of contrast-induced renal dysfunction: the RAPPID examine. J Am.Coll.Cardiol. 6-18-2003;41(12):2114-2118. View summary.

Baker, W. L., Anglade, M. W., Baker, E. L., White, C. M., Kluger, J., and Coleman, C. I. Use of N-acetylcysteine to scale back post-cardiothoracic surgical procedure issues: a meta-analysis. Eur.J Cardiothorac.Surg 2009;35(3):521-527. View summary.

Bakker, J., Zhang, H., Depierreux, M., van, Asbeck S., and Vincent, J. L. Results of N-acetylcysteine in endotoxic shock. J Crit Care 1994;9(4):236-243. View summary.

Ballke, E. H., Wiersbitzky, S., Mahner, B., and Konig, A. The impact of N-acetyl-cysteine (Mucosolvin) on the transmural potential distinction of the mucosa in kids. Padiatr.Grenzgeb. 1992;31(2):97-101. View summary.

Banner, W., Jr., Koch, M., Capin, D. M., Hopf, S. B., Chang, S., and Tong, T. G. Experimental chelation remedy in chromium, lead, and boron intoxication with N-acetylcysteine and different compounds. Toxicol.Appl.Pharmacol 3-30-1986;83(1):142-147. View summary.

Baran, D. Klinischer Doppelblindversuch mit oralem Acetylcystein und Placebo bei zystischer Fibrose. Therapiewoche 1980;30:2034-2039.

Baranska-Kosakowska, A., Zakliczynski, M., Przybylski, R., and Zembala, M. Position of N-acetylcysteine on renal perform in sufferers after orthotopic coronary heart transplantation present process coronary angiography. Transplant.Proc 2007;39(9):2853-2855. View summary.

Bariffi, F. and Seccia, A. Ricerca controllata doppio-cieca sull’ attivita dell’ acetilcisteina per through orale in campo bronco-pneumologico. Clin.Ter. 1973;66:311-320.

Barr, L. F. and Kolodner, Ok. N-acetylcysteine and fenoldopam shield the renal perform of sufferers with continual renal insufficiency present process cardiac surgical procedure. Crit Care Med 2008;36(5):1427-1435. View summary.

Barreto, R. Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate. Nephrol.Nurs.J 2007;34(4):417-421. View summary.

Bateman, D. N., Woodhouse, Ok. W., and Rawlins, M. D. Antagonistic reactions to N-acetylcysteine. Hum Toxicol. 1984;3(5):393-398. View summary.

Bellomo, G., Giudice, S., and Ganci, C. [Comparative study of the efficacy of acetylcysteine in oral and intramuscular administration in acute respiratory diseases in pediatrics]. Minerva Pediatr 5-26-1973;25(19):844-849. View summary.

Beloqui, O., Prieto, J., Suarez, M., Gil, B., Qian, C. H., Garcia, N., and Civeira, M. P. N-acetyl cysteine enhances the response to interferon-alpha in continual hepatitis C: a pilot examine. J.Interferon Res. 1993;13(4):279-282. View summary.

Berk, M., Copolov, D. L., Dean, O., Lu, Ok., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., and Bush, A. I. N-acetyl cysteine for depressive signs in bipolar disorder–a double-blind randomized placebo-controlled trial. Biol Psychiatry 9-15-2008;64(6):468-475. View summary.

Berk, M., Copolov, D., Dean, O., Lu, Ok., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., Ording-Jespersen, S., Little, J., Conus, P., Cuenod, M., Do, Ok. Q., and Bush, A. I. N-acetyl cysteine as a glutathione precursor for schizophrenia–a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 9-1-2008;64(5):361-368. View summary.

Bernard, G. R., Wheeler, A. P., Arons, M. M., Morris, P. E., Paz, H. L., Russell, J. A., and Wright, P. E. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Research Group. Chest 1997;112(1):164-172. View summary.

BERNSTEIN, I. L. and AUSDENMOORE, R. W. IATROGENIC BRONCHOSPASM OCCURRING DURING CLINICAL TRIALS OF A NEW MUCOLYTIC AGENT, ACETYLCYSTEINE. Dis.Chest 1964;46:469-473. View summary.

Bibi, H., Seifert, B., Oullette, M., and Belik, J. Intratracheal N-acetylcysteine use in infants with continual lung illness. Acta Paediatr. 1992;81(4):335-339. View summary.

Bijlmer-Iest, J. C., Baart, de la Faille, van Asbeck, B. S., van, Hattum J., van, Weelden H., Marx, J. J., and Koningsberger, J. C. Protoporphyrin photosensitivity can’t be attenuated by oral N-acetylcysteine. Photodermatol.Photoimmunol.Photomed. 1992;9(6):245-249. View summary.

Binet, H., Simonart, T., Van Vooren, J. P., Heenen, M., Liesnard, C., Delforge, M. L., Farber, C. M., and Guardian, D. Porphyria cutanea tarda in a human immunodeficiency virus-infected affected person: remedy with N-acetyl-cysteine. Int.J.Dermatol. 1998;37(9):718-719. View summary.

Biscatti, G., Bruschelli, M., Damonte, G., and Capozzi, F. [Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics]. Minerva Pediatr 7-28-1972;24(26):1075-1084. View summary.

Block, Ok. I., Koch, A. C., Mead, M. N., Tothy, P. Ok., Newman, R. A., and Gyllenhaal, C. Impression of antioxidant supplementation on chemotherapeutic toxicity: a scientific evaluate of the proof from randomized managed trials. Int.J Most cancers 9-15-2008;123(6):1227-1239. View summary.

Boesgaard, S., Aldershvile, J., and Poulsen, H. E. Preventive administration of intravenous N-acetylcysteine and improvement of tolerance to isosorbide dinitrate in sufferers with angina pectoris. Circulation 1992;85(1):143-149. View summary.

Boman, G., Backer, U., Larsson, S., Melander, B., and Wahlander, L. Oral acetylcysteine reduces exacerbation price in continual bronchitis: report of a trial organized by the Swedish Society for Pulmonary Illnesses. Eur J Respir.Dis 1983;64(6):405-415. View summary.

Borgstrom, L., Kagedal, B., and Paulsen, O. Pharmacokinetics of N-acetylcysteine in man. Eur.J Clin Pharmacol 1986;31(2):217-222. View summary.

Bowles, W. H. and Goral, V. Scientific trial of the anti-plaque exercise of a mucolytic agent, N-Acetyl Cysteine. Dent.Hyg.(Stylish.) 1985;59(10):454-456. View summary.

Braganza, J. M., Holmes, A. M., Morton, A. R., Stalley, L., Ku, R., and Kisher, R. Acetylcysteine to deal with issues of pancreatitis. Lancet 4-19-1986;1(8486):914-915. View summary.

Braum, D. Randomisierte Vergleichsstudie Sinupret Dragées vs. Fluimucil Granulat bei akuter und chronischer Sinusitis. 1986;

Bridgeman, M. M., Marsden, M., MacNee, W., Flenley, D. C., and Ryle, A. P. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after remedy with N-acetylcysteine. Thorax 1991;46(1):39-42. View summary.

Bridgeman, M. M., Marsden, M., Selby, C., Morrison, D., and MacNee, W. Impact of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 1994;49(7):670-675. View summary.

Briguori, C., Manganelli, F., Scarpato, P., Elia, P. P., Golia, B., Riviezzo, G., Lepore, S., Librera, M., Villari, B., Colombo, A., and Ricciardelli, B. Acetylcysteine and distinction agent-associated nephrotoxicity. J Am Coll.Cardiol. 7-17-2002;40(2):298-303. View summary.

Brocard, H., Charpin, J., and Germouty, J. [Multicenter, double-blind study of oral acetylcysteine vs. placebo]. Eur.J Respir.Dis.Suppl 1980;111:65-69. View summary.

Brok, J., Buckley, N., and Gluud, C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database.Syst.Rev. 2006;(2):CD003328. View summary.

Buckley, N. A., Whyte, I. M., O’Connell, D. L., and Dawson, A. H. Activated charcoal reduces the necessity for N-acetylcysteine remedy after acetaminophen (paracetamol) overdose. J Toxicol.Clin Toxicol. 1999;37(6):753-757. View summary.

Buckley, N. A., Whyte, I. M., O’Connell, D. L., and Dawson, A. H. Oral or intravenous N-acetylcysteine: which is the remedy of selection for acetaminophen (paracetamol) poisoning? J Toxicol.Clin Toxicol. 1999;37(6):759-767. View summary.

Burgunder, J. M., Varriale, A., and Lauterburg, B. H. Impact of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur.J Clin Pharmacol 1989;36(2):127-131. View summary.

Burkhart, Ok. Ok., Janco, N., Kulig, Ok. W., and Rumack, B. H. Cimetidine as adjunctive remedy for acetaminophen overdose. Hum Exp.Toxicol. 1995;14(3):299-304. View summary.

Burns, Ok. E., Chu, M. W., Novick, R. J., Fox, S. A., Gallo, Ok., Martin, C. M., Stitt, L. W., Heidenheim, A. P., Myers, M. L., and Moist, L. Perioperative N-acetylcysteine to forestall renal dysfunction in high-risk sufferers present process cabg surgical procedure: a randomized managed trial. JAMA 7-20-2005;294(3):342-350. View summary.

Carbonell, N., Blasco, M., Sanjuan, R., Perez-Sancho, E., Sanchis, J., Insa, L., Bodi, V., Nunez, J., Garcia-Ramon, R., and Miguel, A. Intravenous N-acetylcysteine for stopping contrast-induced nephropathy: a randomised trial. Int J Cardiol. 1-31-2007;115(1):57-62. View summary.

Casola, G. and vanSonnenberg, E. Pores and skin harm from acetylcysteine leak throughout percutaneous abscess drainage. Radiology 1984;152(1):233. View summary.

Cato, A., Goldstein, I., and Millman, M. A double-blind parallel examine of acetylcysteine-isoproterenol and saline-isoproterenol in sufferers with continual obstructive lung illness. J Int Med Res 1977;5(3):175-183. View summary.

Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., and Shea, T. B. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer’s illness: a 1-year, open-label pilot examine with an 16-month caregiver extension. Am.J Alzheimers.Dis Different Demen. 12-20-2008;23(6):571-585. View summary.

Chan, T. Y. and Critchley, J. A. Antagonistic reactions to intravenous N-acetylcysteine in Chinese language sufferers with paracetamol (acetaminophen) poisoning. Hum Exp.Toxicol. 1994;13(8):542-544. View summary.

Charley, G., Dean, B. S., and Krenzelok, E. P. Oral N-acetylcysteine-induced urticaria: a case report. Vet.Hum Toxicol. 1987;29:477.

Charunwatthana, P., Abul, Faiz M., Ruangveerayut, R., Maude, R. J., Rahman, M. R., Roberts, L. J., Moore, Ok., Bin, Yunus E., Hoque, M. G., Hasan, M. U., Lee, S. J., Pukrittayakamee, S., Newton, P. N., White, N. J., Day, N. P., and Dondorp, A. M. N-acetylcysteine as adjunctive remedy in extreme malaria: a randomized, double-blinded placebo-controlled scientific trial. Crit Care Med 2009;37(2):516-522. View summary.

Chen, N., Aleksa, Ok., Woodland, C., Rieder, M., and Koren, G. Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: scientific pharmacokinetic concerns. Can J Clin Pharmacol 2007;14(2):e246-e250. View summary.

Chen, P., Bauer, G., Mitchell, J., Issue, R., Markham, R., and Schwartz, D. H. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid improve contact-dependent progress of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and enhance restoration of HIV from human-PBMC SCID mice. AIDS 1997;11(1):33-41. View summary.

Chirkov, Y. Y. and Horowitz, J. D. N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation. J Cardiovasc.Pharmacol 1996;28(3):375-380. View summary.

Chodosh, S. and Medici, T. C. The bronchial epithelium in continual bronchitis. I. Exfoliative cytology throughout steady, acute bacterial an infection and restoration phases. Am Rev.Respir.Dis. 1971;104(6):888-898. View summary.

Chodosh, S., Baigelman, W., Medici, T. C., and Enslein, Ok. Lengthy-term residence use of acetylcysteine in continual bronchitis. Curr Ther Res Clin Exp. 1975;17(4):319-334. View summary.

Cimino, L., Belisario, M. A., Intrieri, M., D’Ascoli, B., Sacchetti, L., Salvatore, F., and Budillon, G. Impact of N-acetyl-cysteine on lymphomonocyte glutathione and response to interferon remedy in C-virus continual hepatitis. Ital.J.Gastroenterol.Hepatol. 1998;30(2):189-193. View summary.

Cotgreave, I. A. and Moldeus, P. Methodologies for the evaluation of diminished and oxidized N-acetylcysteine in organic programs. Biopharm.Drug Dispos. 1987;8(4):365-375. View summary.

Coyle, L. C., Rodriguez, A., Jeschke, R. E., Simon-Lee, A., Abbott, Ok. C., and Taylor, A. J. Acetylcysteine In Diabetes (AID): a randomized examine of acetylcysteine for the prevention of distinction nephropathy in diabetics. Am Coronary heart J 2006;151(5):1032-12. View summary.

D’Agostini, F., Balansky, R. M., Camoirano, A., and De, Flora S. Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis. Int J Most cancers 12-1-2000;88(5):702-707. View summary.

Dal, Negro R., Visconti, M., Trevisan, F., Bertacco, S., Micheletto, C., and Tognella, S. Erdosteine enhances airway response to salbutamol in sufferers with mild-to-moderate COPD. Ther Adv.Respir.Dis. 2008;2(5):271-277. View summary.

Dano, G. Bronchospasm attributable to acetylcysteine in kids with bronchial bronchial asthma. Acta Allergol. 1971;26(3):181-190. View summary.

Dawson, A. H., Henry, D. A., and McEwen, J. Antagonistic reactions to N-acetylcysteine throughout remedy for paracetamol poisoning. Med J Aust. 3-20-1989;150(6):329-331. View summary.

de Gussem, E. M., Snijder, R. J., Disch, F. J., Zanen, P., Westermann, C. J., and Mager, J. J. The impact of N-acetylcysteine on epistaxis and high quality of life in sufferers with HHT: a pilot examine. Rhinology 2009;47(1):85-88. View summary.

De Rosa, S. C., Zaretsky, M. D., Dubs, J. G., Roederer, M., Anderson, M., Inexperienced, A., Mitra, D., Watanabe, N., Nakamura, H., Tjioe, I., Deresinski, S. C., Moore, W. A., Ela, S. W., Parks, D., Herzenberg, L. A., and Herzenberg, L. A. N-acetylcysteine replenishes glutathione in HIV an infection. Eur.J Clin Make investments 2000;30(10):915-929. View summary.

De, Caro L., Ghizzi, A., Costa, R., Longo, A., Ventresca, G. P., and Lodola, E. Pharmacokinetics and bioavailability of oral acetylcysteine in wholesome volunteers. Arzneimittelforschung. 1989;39(3):382-386. View summary.

de, Quay B., Malinverni, R., and Lauterburg, B. H. Glutathione depletion in HIV-infected sufferers: position of cysteine deficiency and impact of oral N-acetylcysteine. AIDS 1992;6(8):815-819. View summary.

Decramer, M., Rutten-van, Molken M., Dekhuijzen, P. N., Troosters, T., van, Herwaarden C., Pellegrino, R., van Schayck, C. P., Olivieri, D., Del, Donno M., De, Backer W., Lankhorst, I., and Ardia, A. Results of N-acetylcysteine on outcomes in continual obstructive pulmonary illness (Bronchitis Randomized on NAC Price-Utility Research, BRONCUS): a randomised placebo-controlled trial. Lancet 4-30-2005;365(9470):1552-1560. View summary.

Delneste, Y., Jeannin, P., Potier, L., Romero, P., and Bonnefoy, J. Y. N-acetyl-L-cysteine displays antitumoral exercise by rising tumor necrosis issue alpha-dependent T-cell cytotoxicity. Blood 8-1-1997;90(3):1124-1132. View summary.

Denton, R., Kwart, H., and Litt, M. N-acetylcysteine in cystic fibrosis. Mechanical and chemical components in remedy by aerosol. Am Rev.Respir.Dis. 1967;95(4):643-651. View summary.

di Mario, F., Cavallaro, L. G., Nouvenne, A., Stefani, N., Cavestro, G. M., Iori, V., Maino, M., Comparato, G., Fanigliulo, L., Morana, E., Pilotto, A., Martelli, L., Martelli, M., Leandro, G., and Franze, A. A curcumin-based 1-week triple remedy for eradication of Helicobacter pylori an infection: one thing to be taught from failure? Helicobacter. 2007;12(3):238-243. View summary.

Diaz-Sandoval, L. J., Kosowsky, B. D., and Losordo, D. W. Acetylcysteine to forestall angiography-related renal tissue damage (the APART trial). Am J Cardiol. 2-1-2002;89(3):356-358. View summary.

Dietzsch, H. J., Berger, G., Gottschalk, B., Leupold, W., Mittenzwey, Ok. W., Rupprecht, E., and Wunderlich, P. [Experiences with oral N-acetyl-cysteine treatment in children suffering from cystic fibrosis (author’s transl)]. Z.Erkr.Atmungsorgane. 1980;155(1):109-113. View summary.

DiMari, J., Megyesi, J., Udvarhelyi, N., Worth, P., Davis, R., and Safirstein, R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997;272(3 Pt 2):F292-F298. View summary.

Duijvestijn, Y. C. and Model, P. L. Systematic evaluate of N-acetylcysteine in cystic fibrosis. Acta Paediatr. 1999;88(1):38-41. View summary.

Durham, J. D., Caputo, C., Dokko, J., Zaharakis, T., Pahlavan, M., Keltz, J., Dutka, P., Marzo, Ok., Maesaka, J. Ok., and Fishbane, S. A randomized managed trial of N-acetylcysteine to forestall distinction nephropathy in cardiac angiography. Kidney Int 2002;62(6):2202-2207. View summary.

Efrati, S., Dishy, V., Averbukh, M., Blatt, A., Krakover, R., Weisgarten, J., Morrow, J. D., Stein, M. C., and Golik, A. The impact of N-acetylcysteine on renal perform, nitric oxide, and oxidative stress after angiography. Kidney Int 2003;64(6):2182-2187. View summary.

Ege, T., Eskiocak, S., Edis, M., and Duran, E. The position of N-acetylcysteine in decrease extremity ischemia/reperfusions. J Cardiovasc.Surg (Torino) 2006;47(5):563-568. View summary.

Eklund, A., Eriksson, O., Hakansson, L., Larsson, Ok., Ohlsson, Ok., Venge, P., Bergstrand, H., Bjornson, A., Brattsand, R., Glennow, C., and . Oral N-acetylcysteine reduces chosen humoral markers of inflammatory cell exercise in BAL fluid from wholesome people who smoke: correlation to results on mobile variables. Eur.Respir.J 1988;1(9):832-838. View summary.

El, Mahmoud R., Le, Feuvre C., Le Quan Sang, Ok. H., Helft, G., Beygui, F., Batisse, J. P., and Metzger, J. P. [Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography]. Arch Mal Coeur Vaiss. 2003;96(12):1157-1161. View summary.

El-Hamamsy, I., Stevens, L. M., Provider, M., Pellerin, M., Bouchard, D., Demers, P., Cartier, R., Web page, P., and Perrault, L. P. Impact of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgical procedure: a randomized, double-blind, placebo-controlled scientific trial. J Thorac.Cardiovasc.Surg 2007;133(1):7-12. View summary.

Elnashar, A., Fahmy, M., Mansour, A., and Ibrahim, Ok. N-acetyl cysteine vs. metformin in remedy of clomiphene citrate-resistant polycystic ovary syndrome: a potential randomized managed examine. Fertil.Steril. 2007;88(2):406-409. View summary.

Endo, A. and Watanabe, T. Evaluation of protecting exercise of N-acetylcysteine in opposition to teratogenicity of heavy metals. Reprod.Toxicol. 1988;2(2):141-144. View summary.

Eren, N., Cakir, O., Oruc, A., Kaya, Z., and Erdinc, L. Results of N-acetylcysteine on pulmonary perform in sufferers present process coronary artery bypass surgical procedure with cardiopulmonary bypass. Perfusion 2003;18(6):345-350. View summary.

Eylar, E. H., Baez, I., Vazquez, A., and Yamamura, Y. N-acetylcysteine (NAC) enhances interleukin-2 however suppresses interleukin-4 secretion from regular and HIV+ CD4+ T-cells. Cell Mol.Biol (Noisy.-le-grand) 1995;41 Suppl 1:S35-S40. View summary.

Ferreira, L. F. and Reid, M. B. Muscle-derived ROS and thiol regulation in muscle fatigue. J Appl Physiol 2008;104(3):853-860. View summary.

Fischer, U. M., Tossios, P., and Mehlhorn, U. Renal safety by radical scavenging in cardiac surgical procedure sufferers. Curr Med Res Opin. 2005;21(8):1161-1164. View summary.

Fishbane, S. N-acetylcysteine within the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol. 2008;3(1):281-287. View summary.

Flescher, E. and Fingrut, O. Suppression of interleukin 2 biosynthesis by three modes of oxidative mobile stress: selective prevention by N-acetyl cysteine. Cytokine 2000;12(5):495-498. View summary.

Foschino Barbaro, M. P., Serviddio, G., Resta, O., Rollo, T., Tamborra, R., Elisiana, Carpagnano G., Vendemiale, G., and Altomare, E. Oxygen remedy at low move causes oxidative stress in continual obstructive pulmonary illness: Prevention by N-acetyl cysteine. Free Radic.Res 2005;39(10):1111-1118. View summary.

Fulghesu, A. M., Ciampelli, M., Muzj, G., Belosi, C., Selvaggi, L., Ayala, G. F., and Lanzone, A. N-acetyl-cysteine remedy improves insulin sensitivity in girls with polycystic ovary syndrome. Fertil.Steril. 2002;77(6):1128-1135. View summary.

Fung, J. W. S. C., Chan, W., Kum, W., and et al. Can N-acetylcysteine actually stop contrast-induced nephropathy in sufferers with continual renal insufficiency? A randomized examine and pooled evaluation. Eur Coronary heart J 2003;24(S136) View summary.

Fung, J. W., Szeto, C. C., Chan, W. W., Kum, L. C., Chan, A. Ok., Wong, J. T., Wu, E. B., Yip, G. W., Chan, J. Y., Yu, C. M., Woo, Ok. S., and Sanderson, J. E. Impact of N-acetylcysteine for prevention of distinction nephropathy in sufferers with reasonable to extreme renal insufficiency: a randomized trial. Am.J Kidney Dis. 2004;43(5):801-808. View summary.

Gass, J. T. and Olive, M. F. Glutamatergic substrates of drug dependancy and alcoholism. Biochem.Pharmacol 1-1-2008;75(1):218-265. View summary.

Gavish, D. and Breslow, J. L. Lipoprotein(a) discount by N-acetylcysteine. Lancet 1-26-1991;337(8735):203-204. View summary.

Gawenda, M., Moller, A., Wassmer, G., and Brunkwall, J. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine]. Zentralbl.Chir 2007;132(3):227-231. View summary.

Gepts, L. Oral acetylcysteine remedy in exacerbation of continual bronchitis in 49 sufferers. Eur J Respir.Dis 1980;61(Suppl 111):109.

Gervais, S., Lussier-Labelle, F., and Beaudet, G. Anaphylactoid response to acetylcysteine. Clin Pharm 1984;3(6):586-587. View summary.

Ghanei, M., Shohrati, M., Jafari, M., Ghaderi, S., Alaeddini, F., and Aslani, J. N-acetylcysteine improves the scientific circumstances of mustard gas-exposed sufferers with regular pulmonary perform take a look at. Primary Clin Pharmacol Toxicol. 2008;103(5):428-432. View summary.

Girardi, G. and Elias, M. M. Effectiveness of N-acetylcysteine in defending in opposition to mercuric chloride-induced nephrotoxicity. Toxicology 4-8-1991;67(2):155-164. View summary.

Goldenberg, I. J. M., Matetzki, S., Schechter, M, and et al. Distinction-associated nephropathy and scientific end result of sufferers with continual renal insufficiency present process cardiac catheterization: lack of additive good thing about acetylcysteine to saline hydration. J Am Coll.Cardiol. 2003;41:537A.

Goldenberg, I., Shechter, M., Matetzky, S., Jonas, M., Adam, M., Pres, H., Elian, D., Agranat, O., Schwammenthal, E., and Guetta, V. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized managed trial and evaluate of the present literature. Eur.Coronary heart J 2004;25(3):212-218. View summary.

Gomes, V. O., Caramori, P., Lasevitch, R., Brizolara, A., Nery, P., Araujo, A., Hemesath, M., and Brito, F. S. Jr. Prevention of contrast-induced nephropathy with N-acetylcysteine in sufferers present process coronary angiography: a randomized multicenter trial. Circulation 2003;108:IV-460.

Gonzales, D. A., Norsworthy, Ok. J., Kern, S. J., Banks, S., Sieving, P. C., Star, R. A., Natanson, C., and Danner, R. L. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC.Med 2007;5:32. View summary.

Gottschalk, B. [Therapy of mucoviscidosis using aerosols]. Dtsch.Gesundheitsw. 6-15-1972;27(24):1121-1124. View summary.

Gotz, M., Kraemer, R., Kerrebijn, Ok. F., and Popow, C. Oral acetylcysteine in cystic fibrosis. A co-operative examine. Eur.J Respir.Dis.Suppl 1980;111:122-126. View summary.

Grant, J. E., Kim, S. W., and Odlaug, B. L. N-acetyl cysteine, a glutamate-modulating agent, within the remedy of pathological playing: a pilot examine. Biol Psychiatry 9-15-2007;62(6):652-657. View summary.

Grant, P. R., Black, A., Garcia, N., Prieto, J., and Garson, J. A. Mixture remedy with interferon-alpha plus N-acetyl cysteine for continual hepatitis C: a placebo managed double-blind multicentre examine. J.Med.Virol. 2000;61(4):439-442. View summary.

Grassi, C. and Morandini, G. C. A managed trial of intermittent oral acetylcysteine within the long-term remedy of continual bronchitis. Eur.J Clin Pharmacol 3-22-1976;09(5-6):393-396. View summary.

Grassi, C., Morandini, G. C., and Frigerio, G. Scientific analysis of systemic acetylcysteine by totally different routes of administration. Curr Ther Res Clin Exp. 1973;15(4):165-179. View summary.

Grater, W. C. and Cato, A. Double-blind examine of acetylcysteine-isoproterenol and saline-isoproterenol in non-hospitalized sufferers with bronchial asthma. Curr Ther Res Clin Exp. 1973;15(9):660-671. View summary.

Grimble, G. Ok. Antagonistic gastrointestinal results of arginine and associated amino acids. J Nutr 2007;137(6 Suppl 2):1693S-1701S. View summary.

Guijarro, L. G., Mate, J., Gisbert, J. P., Perez-Calle, J. L., Marin-Jimenez, I., Arriaza, E., Olleros, T., Delgado, M., Castillejo, M. S., Prieto-Merino, D., Gonzalez, Lara, V, and Pena, A. S. N-acetyl-L-cysteine mixed with mesalamine within the remedy of ulcerative colitis: randomized, placebo-controlled pilot examine. World J Gastroenterol. 5-14-2008;14(18):2851-2857. View summary.

Gunduz, H., Karabay, O., Tamer, A., Ozaras, R., Mert, A., and Tabak, O. F. N-acetyl cysteine remedy in acute viral hepatitis. World J.Gastroenterol. 2003;9(12):2698-2700. View summary.

Gurbuz, A. Ok., Ozel, A. M., Ozturk, R., Yildirim, S., Yazgan, Y., and Demirturk, L. Impact of N-acetyl cysteine on Helicobacter pylori. South.Med J 2005;98(11):1095-1097. View summary.

Gurtoo, H. L., Marinello, A. J., Berrigan, M. J., Bansal, S. Ok., Paul, B., Pavelic, Z. P., and Struck, R. F. Impact of thiols on toxicity and carcinostatic exercise of cyclophosphamide. Semin.Oncol 1983;10(1 Suppl 1):35-45. View summary.

Haase, M., Haase-Fielitz, A., Bagshaw, S. M., Reade, M. C., Morgera, S., Seevenayagam, S., Matalanis, G., Buxton, B., Doolan, L., and Bellomo, R. Part II, randomized, managed trial of high-dose N-acetylcysteine in high-risk cardiac surgical procedure sufferers. Crit Care Med 2007;35(5):1324-1331. View summary.

Hansen, N. C., Skriver, A., Brorsen-Riis, L., Balslov, S., Evald, T., Maltbaek, N., Gunnersen, G., Garsdal, P., Sander, P., Pedersen, J. Z., and . Orally administered N-acetylcysteine might enhance basic well-being in sufferers with gentle continual bronchitis. Respir.Med 1994;88(7):531-535. View summary.

Harrison, P. M., Keays, R., Bray, G. P., Alexander, G. J., and Williams, R. Improved end result of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 6-30-1990;335(8705):1572-1573. View summary.

Hart, A. M., Terenghi, G., and Wiberg, M. Neuronal loss of life after peripheral nerve damage and experimental methods for neuroprotection. Neurol.Res. 2008;30(10):999-1011. View summary.

Heng, A. E., Cellarier, E., Aublet-Cuvelier, B., Decalf, V., Motreff, P., Marcaggi, X., Deteix, P., and Souweine, B. Is remedy with N-acetylcysteine to forestall contrast-induced nephropathy when utilizing bicarbonate hydration outdated? Clin Nephrol. 2008;70(6):475-484. View summary.

Henneghien, C., Remacle, P., and Bruart, J. Research of the Nacetylcysteine (NAC) by oral or intravenous administration in continual bronchitis. Curr Ther Res 1983;34:750-756.

Hershkovitz, E., Shorer, Z., Levitas, A., and Tal, A. Standing epilepticus following intravenous N-acetylcysteine remedy. Isr.J Med Sci 1996;32(11):1102-1104. View summary.

Hirsch, S. R. and Kory, R. C. An analysis of the impact of nebulized N-acetylcysteine on sputum consistency. J Allergy 1967;39(5):265-273. View summary.

Ho, Ok. M. and Morgan, D. J. Meta-analysis of N-acetylcysteine to forestall acute renal failure after main surgical procedure. Am J Kidney Dis. 2009;53(1):33-40. View summary.

Ho, S. W. and Beilin, L. J. Bronchial asthma related to N-acetylcysteine infusion and paracetamol poisoning: report of two circumstances. Br Med J (Clin Res Ed) 9-24-1983;287(6396):876-877. View summary.

Holdiness, M. R. Scientific pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet. 1991;20(2):123-134. View summary.

Horl, W. H. [Contrast induced nephropathy]. Wien.Klin.Wochenschr. 2009;121(1-2):15-32. View summary.

Horowitz, J. D., Henry, C. A., Syrjanen, M. L., Louis, W. J., Fish, R. D., Smith, T. W., and Antman, E. M. Mixed use of nitroglycerin and N-acetylcysteine within the administration of unstable angina pectoris. Circulation 1988;77(4):787-794. View summary.

Howatt, W. F. and DeMuth, G. R. A double-blind examine of the usage of acetylcysteine in sufferers with cystic fibrosis. Univ Mich.Med Cent.J 1966;32(2):82-85. View summary.

Hultberg, B., Andersson, A., Masson, P., Larson, M., and Tunek, A. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Make investments 1994;54(6):417-422. View summary.

Huynh, H. Q., Couper, R. T., Tran, C. D., Moore, L., Kelso, R., and Butler, R. N. N-acetylcysteine, a novel remedy for Helicobacter pylori an infection. Dig.Dis.Sci 2004;49(11-12):1853-1861. View summary.

Hynninen, M. S., Niemi, T. T., Poyhia, R., Raininko, E. I., Salmenpera, M. T., Lepantalo, M. J., Railo, M. J., and Tallgren, M. Ok. N-acetylcysteine for the prevention of kidney damage in stomach aortic surgical procedure: a randomized, double-blind, placebo-controlled trial. Anesth.Analg. 2006;102(6):1638-1645. View summary.

Inoue, S., Yamamoto, I., Akieda, Ok., Sekiguchi, H., Otuka, H., Morita, S., Nakagawa, Y., and Inokuchi, S. [Alcohol abuse case of severe liver dysfunction induced by acetaminophen poisoning which was diagnosed as non-hepatic toxicity on admission]. Chudoku.Kenkyu 2006;19(3):265-271. View summary.

Ivanovski, O., Nikolov, I. G., Drueke, B. T., and Massy, A. Z. Atherosclerosis and vascular calcification in uraemia – a brand new experimental mannequin. Prilozi. 2007;28(2):11-24. View summary.

Jackson, I. M., Barnes, J., and Cooksey, P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in continual bronchitis: a double-blind placebo managed examine. J Int Med Res 1984;12(3):198-206. View summary.

Jensen, T., Kharazmi, A., Schiotz, P. O., Nielsen, H., Stenvang, Pedersen S., Stafanger, G., Koch, C., and Hoiby, N. Impact of oral N-acetylcysteine administration on human blood neutrophil and monocyte perform. APMIS 1988;96(1):62-67. View summary.

Jepsen, S., Herlevsen, P., Knudsen, P., Bud, M. I., and Klausen, N. O. Antioxidant remedy with N-acetylcysteine throughout grownup respiratory misery syndrome: a potential, randomized, placebo-controlled examine. Crit Care Med 1992;20(7):918-923. View summary.

Jiang, B., Haverty, M., and Brecher, P. N-acetyl-L-cysteine enhances interleukin-1beta-induced nitric oxide synthase expression. Hypertension 1999;34(4 Pt 1):574-579. View summary.

Jo, S. H., Koo, B. Ok., Park, J. S., Kang, H. J., Kim, Y. J., Kim, H. L., Chae, I. H., Choi, D. J., Sohn, D. W., Oh, B. H., Park, Y. B., Choi, Y. S., and Kim, H. S. N-acetylcysteine versus AScorbic acid for stopping contrast-Induced nephropathy in sufferers with renal insufficiency present process coronary angiography NASPI study-a potential randomized managed trial. Am Coronary heart J 2009;157(3):576-583. View summary.

Johnston, R. E., Hawkins, H. C., and Weikel, J. H., Jr. The toxicity of N-acetylcysteine in laboratory animals. Semin.Oncol 1983;10(1 Suppl 1):17-24. View summary.

Jones, A. L., Bangash, I. H., Bouchier, I. A., and Hayes, P. C. Portal and systemic haemodynamic motion of N-acetylcysteine in sufferers with steady cirrhosis. Intestine 1994;35(9):1290-1293. View summary.

Jones, A. L., Jarvie, D. R., Simpson, D., Hayes, P. C., and Prescott, L. F. Pharmacokinetics of N-acetylcysteine are altered in sufferers with continual liver illness. Aliment.Pharmacol Ther 1997;11(4):787-791. View summary.

Kalebic, T., Kinter, A., Poli, G., Anderson, M. E., Meister, A., and Fauci, A. S. Suppression of human immunodeficiency virus expression in chronically contaminated monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl.Acad.Sci U.S.A 2-1-1991;88(3):986-990. View summary.

Kay, J., Chow, W. H., Chan, T. M., Lo, S. Ok., Kwok, O. H., Yip, A., Fan, Ok., Lee, C. H., and Lam, W. F. Acetylcysteine for prevention of acute deterioration of renal perform following elective coronary angiography and intervention: a randomized managed trial. JAMA 2-5-2003;289(5):553-558. View summary.

Keays, R., Harrison, P. M., Wendon, J. A., Forbes, A., Gove, C., Alexander, G. J., and Williams, R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a potential managed trial. BMJ 10-26-1991;303(6809):1026-1029. View summary.

Kefer, J. M., Hanet, C. E., Boitte, S., Wilmotte, L., and De, Kock M. Acetylcysteine, coronary process and prevention of contrast-induced worsening of renal perform: which profit for which affected person? Acta Cardiol. 2003;58(6):555-560. View summary.

Kelly, M. Ok., Wicker, R. J., Barstow, T. J., and Harms, C. A. Results of N-acetylcysteine on respiratory muscle fatigue throughout heavy train. Respir.Physiol Neurobiol. 1-1-2009;165(1):67-72. View summary.

Kerr, F., Dawson, A., Whyte, I. M., Buckley, N., Murray, L., Graudins, A., Chan, B., and Trudinger, B. The Australasian Scientific Toxicology Investigators Collaboration randomized trial of various loading infusion charges of N-acetylcysteine. Ann Emerg.Med 2005;45(4):402-408. View summary.

Khan, A. W., Fuller, B. J., Shah, S. R., Davidson, B. R., and Rolles, Ok. A potential randomized trial of N-acetyl cysteine administration throughout chilly preservation of the donor liver for transplantation. Ann.Hepatol 2005;4(2):121-126. View summary.

Kharazmi, A., Nielsen, H., and Schiotz, P. O. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol. 1988;10(1):39-46. View summary.

Kilic-Okman, T. and Kucuk, M. N-acetyl-cysteine remedy for polycystic ovary syndrome. Int.J.Gynaecol.Obstet. 2004;85(3):296-297. View summary.

Kinscherf, R., Fischbach, T., Mihm, S., Roth, S., Hohenhaus-Sievert, E., Weiss, C., Edler, L., Bartsch, P., and Droge, W. Impact of glutathione depletion and oral N-acetyl-cysteine remedy on CD4+ and CD8+ cells. FASEB J. 4-1-1994;8(6):448-451. View summary.

Kinter, A. L., Poli, G., and Fauci, A. S. N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently contaminated cells. Trans.Assoc.Am.Physicians 1992;105:36-43. View summary.

Kleinveld, H. A., Demacker, P. N., and Stalenhoef, A. F. Failure of N-acetylcysteine to scale back low-density lipoprotein oxidizability in wholesome topics. Eur.J Clin Pharmacol 1992;43(6):639-642. View summary.

Koksal, H., Rahman, A., Burma, O., Halifeoglu, I., and Bayar, M. Ok. The consequences of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgical procedure. Anadolu.Kardiyol.Derg. 2008;8(6):437-443. View summary.

Komisarof, J. A., Gilkey, G. M., Peters, D. M., Koudelka, C. W., Meyer, M. M., and Smith, S. M. N-acetylcysteine for sufferers with extended hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med 2007;35(2):435-441. View summary.

Koramaz, I., Pulathan, Z., Usta, S., Karahan, S. C., Alver, A., Yaris, E., Kalyoncu, N. I., and Ozcan, F. Cardioprotective impact of cold-blood cardioplegia enriched with N-acetylcysteine throughout coronary artery bypass grafting. Ann Thorac.Surg 2006;81(2):613-618. View summary.

Kory, R. C., Hirsch, S. R., and Giraldo, J. Nebulization of N-acetylcysteine mixed with a bronchodilator in sufferers with continual bronchitis. A managed examine. Chest 1968;54(6):504-509.

Kottgen, M., Busch, A. E., Hug, M. J., Greger, R., and Kunzelmann, Ok. N-Acetyl-L-cysteine and its derivatives activate a Cl- conductance in epithelial cells. Pflugers Arch 1996;431(4):549-555. View summary.

Kramer, S., Dreisbach, L., Lockwood, J., Baldwin, Ok., Kopke, R., Scranton, S., and O’Leary, M. Efficacy of the antioxidant N-acetylcysteine (NAC) in defending ears uncovered to loud music. J Am Acad.Audiol. 2006;17(4):265-278. View summary.

Krishna, M. and Lalmuanpuii, J. Helicobacter pylori remedy. South.Med J 2005;98(11):1068. View summary.

Kuleci, S., Hanta, I., Kocabas, A., and Canacankatan, N. The impact of various remedy modalities on oxidative stress in COPD. Adv.Ther 2008;25(7):710-717. View summary.

Kusano, C., Takao, S., Noma, H., Yoh, H., Aikou, T., Okumura, H., Akiyama, S., Kawamura, M., Makino, M., and Baba, M. N-acetyl cysteine inhibits cell cycle development in pancreatic carcinoma cells. Hum.Cell 2000;13(4):213-220. View summary.

Lameire, N. H. Distinction-induced nephropathy–prevention and threat discount. Nephrol.Dial.Transplant. 2006;21(6):i11-i23. View summary.

Lappas, M., Permezel, M., and Rice, G. E. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine launch, protease exercise, and nuclear factor-kappaB deoxyribonucleic acid-binding exercise in human fetal membranes in vitro. J.Clin.Endocrinol.Metab 2003;88(4):1723-1729. View summary.

LaRowe, S. D., Mardikian, P., Malcolm, R., Myrick, H., Kalivas, P., McFarland, Ok., Saladin, M., McRae, A., and Brady, Ok. Security and tolerability of N-acetylcysteine in cocaine-dependent people. Am J Addict. 2006;15(1):105-110. View summary.

LaRowe, S. D., Myrick, H., Hedden, S., Mardikian, P., Saladin, M., McRae, A., Brady, Ok., Kalivas, P. W., and Malcolm, R. Is cocaine need diminished by N-acetylcysteine? Am J Psychiatry 2007;164(7):1115-1117. View summary.

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., Fornari, E., Meuli, R., Solida, A., Vianin, P., Cuenod, M., Buclin, T., and Do, Ok. Q. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia sufferers. Neuropsychopharmacology 2008;33(9):2187-2199. View summary.

Lawlor, D. Ok., Moist, L., DeRose, G., Harris, Ok. A., Lovell, M. B., Kribs, S. W., Elliot, J., and Forbes, T. L. Prevention of contrast-induced nephropathy in vascular surgical procedure sufferers. Ann Vasc.Surg 2007;21(5):593-597. View summary.

Lemy-Debois, N., Frigerio, G., and Lualdi, P. Oral acetylcysteine in bronchopulmonary illness. Comparative scientific trial with bromhexine. Acta Ther 1978;4(2):125-132.

Leung, Ok. S. and Cottler, L. B. Remedy of pathological playing. Curr Opin.Psychiatry 2009;22(1):69-74. View summary.

Levy, L. and Vredevoe, D. L. The impact of N-acetylcysteine on cyclophosphamide immunoregulation and antitumor exercise. Semin.Oncol 1983;10(1 Suppl 1):7-16. View summary.

Lin, P. C., Lee, M. Y., Wang, W. S., Yen, C. C., Chao, T. C., Hsiao, L. T., Yang, M. H., Chen, P. M., Lin, Ok. P., and Chiou, T. J. N-acetylcysteine has neuroprotective results in opposition to oxaliplatin-based adjuvant chemotherapy in colon most cancers sufferers: preliminary knowledge. Assist.Care Most cancers 2006;14(5):484-487. View summary.

Linden, M., Wieslander, E., Eklund, A., Larsson, Ok., and Brattsand, R. Results of oral N-acetylcysteine on cell content material and macrophage perform in bronchoalveolar lavage from wholesome people who smoke. Eur.Respir.J 1988;1(7):645-650. View summary.

Lengthy-term oral acetylcysteine in continual bronchitis. a double-blind managed examine. Eur.J Respir.Dis.Suppl 1980;111:93-108. View summary.

Look, M. P., Rockstroh, J. Ok., Rao, G. S., Barton, S., Lemoch, H., Kaiser, R., Kupfer, B., Sudhop, T., Spengler, U., and Sauerbruch, T. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected sufferers: a randomized, managed pilot examine. Eur.J Clin Make investments 1998;28(5):389-397. View summary.

Loutrianakis, E., Stella, D., Hussain, A., Lewis, B., Steen, L., Sochanski, M., Leya, F., and Grassman, E. Randomized comparability of fenoldopam and N-acetylcysteine to saline within the prevention of radiocontrast induced nephropathy. J Am Coll.Cardiol. 2003;41:327A.

Macedo, E., Abdulkader, R., Castro, I., Sobrinho, A. C., Yu, L., and Vieira, J. M., Jr. Lack of safety of N-acetylcysteine (NAC) in acute renal failure associated to elective aortic aneurysm repair-a randomized managed trial. Nephrol.Dial.Transplant. 2006;21(7):1863-1869. View summary.

MacNeill, B. D., Harding, S. A., Bazari, H., Patton, Ok. Ok., Colon-Hernadez, P., DeJoseph, D., and Jang, I. Ok. Prophylaxis of contrast-induced nephropathy in sufferers present process coronary angiography. Catheter.Cardiovasc.Interv. 2003;60(4):458-461. View summary.

Maioli, M., Toso, A., Leoncini, M., Gallopin, M., Tedeschi, D., Micheletti, C., and Bellandi, F. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in sufferers with renal dysfunction present process coronary angiography or intervention. J Am Coll.Cardiol. 8-19-2008;52(8):599-604. View summary.

Maioli, M., Toso, A., Leoncini, M., Gallopin, M., Tedeschi, D., Micheletti, C., and Bellandi, F. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in sufferers with renal dysfunction present process coronary angiography or intervention. J.Am.Coll.Cardiol. 8-19-2008;52(8):599-604. View summary.

Majano, P. L., Medina, J., Zubia, I., Sunyer, L., Lara-Pezzi, E., Maldonado-Rodriguez, A., Lopez-Cabrera, M., and Moreno-Otero, R. N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J.Hepatol. 2004;40(4):632-637. View summary.

Malorni, W., Rivabene, R., and Matarrese, P. The antioxidant N-acetyl-cysteine protects cultured epithelial cells from menadione-induced cytopathology. Chem.Biol.Work together. 5-19-1995;96(2):113-123. View summary.

Manov, I., Motanis, H., Frumin, I., and Iancu, T. C. Hepatotoxicity of anti-inflammatory and analgesic medicine: ultrastructural elements. Acta Pharmacol Sin. 2006;27(3):259-272. View summary.

Mant, T. G., Tempowski, J. H., Volans, G. N., and Talbot, J. C. Antagonistic reactions to acetylcysteine and results of overdose. Br Med J (Clin Res Ed) 7-28-1984;289(6439):217-219. View summary.

Marenzi, G., Assanelli, E., Marana, I., Lauri, G., Campodonico, J., Grazi, M., De, Metrio M., Galli, S., Fabbiocchi, F., Montorsi, P., Veglia, F., and Bartorelli, A. L. N-acetylcysteine and contrast-induced nephropathy in main angioplasty. N.Engl.J Med 6-29-2006;354(26):2773-2782. View summary.

McCormick, R. Ok. Osteoporosis: integrating biomarkers and different diagnostic correlates into the administration of bone fragility. Altern.Med Rev. 2007;12(2):113-145. View summary.

McKenna, M. J., Medved, I., Goodman, C. A., Brown, M. J., Bjorksten, A. R., Murphy, Ok. T., Petersen, A. C., Sostaric, S., and Gong, X. N-acetylcysteine attenuates the decline in muscle Na+,Ok+-pump exercise and delays fatigue throughout extended train in people. J Physiol 10-1-2006;576(Pt 1):279-288. View summary.

Meister, R. Langzeittherapie mit Acetylcystein Retard-Tabletten bei Patienten mit chronischer Bronchitis. Eine doppelblinde-placebokontrollierte Studie. Discussion board Prakt Allg Arzt 1986;25:18-22.

Melzer, J., Saller, R., Schapowal, A., and Brignoli, R. Systematic evaluate of scientific knowledge with BNO-101 (Sinupret) within the remedy of sinusitis. Forsch Komplement.Med (2006.) 2006;13(2):78-87. View summary.

Meschi, M., Detrenis, S., Musini, S., Strada, E., and Savazzi, G. Details and fallacies regarding the prevention of distinction medium-induced nephropathy. Crit Care Med 2006;34(8):2060-2068. View summary.

Milewski, J., Rydzewska, G., Degowska, M., Kierzkiewicz, M., and Rydzewski, A. N-acetylcysteine doesn’t stop post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol. 6-21-2006;12(23):3751-3755. View summary.

Millar, A. B., Pavia, D., Agnew, J. E., Lopez-Vidriero, M. T., Lauque, D., and Clarke, S. W. Impact of oral N-acetylcysteine on mucus clearance. Br J Dis.Chest 1985;79(3):262-266. View summary.

Miller, L. F. and Rumack, B. H. Scientific security of excessive oral doses of acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):76-85. View summary.

Millman, M. and Grundon, W. Use of acetylcysteine in bronchial bronchial asthma and emphysema. J Bronchial asthma Res 1969;6(4):199-209. View summary.

Minder, E. I., Schneider-Yin, X., Steurer, J., and Bachmann, L. M. A scientific evaluate of remedy choices for dermal photosensitivity in erythropoietic protoporphyria. Cell Mol.Biol.(Noisy.-le-grand) 2009;55(1):84-97. View summary.

Mitchell, E. A. and Elliott, R. B. Managed trial of oral N-acetylcysteine in cystic fibrosis. Aust.Paediatr.J 1982;18(1):40-42. View summary.

Miyajima, A., Nakashima, J., Tachibana, M., Nakamura, Ok., Hayakawa, M., and Murai, M. N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced results in bladder most cancers cells. Jpn J Most cancers Res 1999;90(5):565-570. View summary.

Molnar, Z., Szakmany, T., and Koszegi, T. Prophylactic N-acetylcysteine decreases serum CRP however not PCT ranges and microalbuminuria following main stomach surgical procedure. A potential, randomised, double-blinded, placebo-controlled scientific trial. Intensive Care Med 2003;29(5):749-755. View summary.

Moore, N. N., Lapsley, M., Norden, A. G., Firth, J. D., Gaunt, M. E., Varty, Ok., and Boyle, J. R. Does N-acetylcysteine stop contrast-induced nephropathy throughout endovascular AAA restore? A randomized managed pilot examine. J Endovasc.Ther 2006;13(5):660-666. View summary.

Moradi, M., Mojtahedzadeh, M., Mandegari, A., Soltan-Sharifi, M. S., Najafi, A., Khajavi, M. R., Hajibabayee, M., and Ghahremani, M. H. The position of glutathione-S-transferase polymorphisms on scientific end result of ALI/ARDS affected person handled with N-acetylcysteine. Respir.Med 2009;103(3):434-441. View summary.

Morgan, L. R., Donley, P. J., Harrison, E. F., and Hunter, H. L. The management of ifosfamide-induced hematuria with N-acetylcysteine in sufferers with superior carcinoma of the lung. Semin.Oncol 1982;9(4 Suppl 1):71-74. View summary.

Morgan, L. R., Holdiness, M. R., and Gillen, L. E. N-acetylcysteine: its bioavailability and interplay with ifosfamide metabolites. Semin.Oncol 1983;10(1 Suppl 1):56-61. View summary.

Myers, C., Bonow, R., Palmeri, S., Jenkins, J., Corden, B., Locker, G., Doroshow, J., and Epstein, S. A randomized managed trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):53-55. View summary.

Nahir, A. M., Scharf, J. M., and Szargel, R. Results of oral N-acetylcysteine on each ocular and oral manifestations of Sjogren’s Syndrome. Curr Ther Res 1989;46:187-192.

Nash, E. F., Stephenson, A., Ratjen, F., and Tullis, E. Nebulized and oral thiol derivatives for pulmonary illness in cystic fibrosis. Cochrane.Database.Syst.Rev. 2009;(1):CD007168. View summary.

Naughton, F., Wijeysundera, D., Karkouti, Ok., Tait, G., and Beattie, W. S. N-acetylcysteine to scale back renal failure after cardiac surgical procedure: a scientific evaluate and meta-analysis. Can J Anaesth. 2008;55(12):827-835. View summary.

Neri, S., Ierna, D., Antoci, S., Campanile, E., D’Amico, R. A., and Noto, R. Affiliation of alpha-interferon and acetyl cysteine in sufferers with continual C hepatitis. Panminerva Med 2000;42(3):187-192. View summary.

Ng, T. M., Shurmur, S. W., Silver, M., Nissen, L. R., O’Leary, E. L., Rigmaiden, R. S., Cieciorka, M., Porter, L. L., Ineck, B. A., Kline, M. E., and Puumala, S. E. Comparability of N-acetylcysteine and fenoldopam for stopping contrast-induced nephropathy (CAFCIN). Int J Cardiol. 5-24-2006;109(3):322-328. View summary.

Nguyen-Ho, P., Dzavik, V., Seidelin, P., Daly, P., Ross, J., McLaughlin, P., Ing, D., Barolet, A., Schwartz, L., and Miner, S. E. N-acetylcysteine doesn’t stop long-term scientific occasions regardless of lowering periprocedural contrast-associated nephropathy. Circulation 2003;108:IV-445.

Niemi, T. T., Munsterhjelm, E., Poyhia, R., Hynninen, M. S., and Salmenpera, M. T. The impact of N-acetylcysteine on blood coagulation and platelet perform in sufferers present process open restore of stomach aortic aneurysm. Blood Coagul.Fibrinolysis 2006;17(1):29-34. View summary.

Nigwekar, S. U. and Kandula, P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac.Surg 2009;87(1):139-147. View summary.

Norris, P. G., Baker, C. S., Roberts, J. E., and Hawk, J. L. Remedy of erythropoietic protoporphyria with N-acetylcysteine. Arch Dermatol 1995;131(3):354-355. View summary.

Ochoa, A., Pellizzon, G., Addala, S., Grines, C., Isayenko, Y., Boura, J., Rempinski, D., O’Neill, W., and Kahn, J. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and pressing coronary angiography and intervention. J Interv.Cardiol. 2004;17(3):159-165. View summary.

Oh, T. E. and Shenfield, G. M. Intravenous N-acetylcysteine for paracetamol poisoning. Med J Aust. 6-28-1980;1(13):664-665. View summary.

Oldemeyer, J. B. C. E, Wuderman, R., Packard, Ok., and et al. Prophylactic acetylcysteine shouldn’t be efficient in stopping contrast-induced nephropathy following coronary angiography. J Am Coll.Cardiol. 2002;84A.

Olsson, B., Johansson, M., Gabrielsson, J., and Bolme, P. Pharmacokinetics and bioavailability of diminished and oxidized N-acetylcysteine. Eur.J Clin Pharmacol 1988;34(1):77-82. View summary.

Oral N-acetylcysteine and exacerbation charges in sufferers with continual bronchitis and extreme airways obstruction. British Thoracic Society Analysis Committee. Thorax 1985;40(11):832-835. View summary.

Orhan, G., Yapici, N., Yuksel, M., Sargin, M., Senay, S., Yalcin, A. S., Aykac, Z., and Aka, S. A. Results of N-acetylcysteine on myocardial ischemia-reperfusion damage in bypass surgical procedure. Coronary heart Vessels 2006;21(1):42-47. View summary.

Ornaghi, F., Ferrini, S., Prati, M., and Giavini, E. The protecting results of N-acetyl-L-cysteine in opposition to methyl mercury embryotoxicity in mice. Fundam.Appl Toxicol. 1993;20(4):437-445. View summary.

Ozaydin, M., Peker, O., Erdogan, D., Kapan, S., Turker, Y., Varol, E., Ozguner, F., Dogan, A., and Ibrisim, E. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a potential, randomized, placebo-controlled pilot examine. Eur.Coronary heart J 2008;29(5):625-631. View summary.

Ozcan, E. E., Guneri, S., Akdeniz, B., Akyildiz, I. Z., Senaslan, O., Baris, N., Aslan, O., and Badak, O. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparability of three regimens for shielding contrast-induced nephropathy in sufferers present process coronary procedures. A single-center potential managed trial. Am Coronary heart J 2007;154(3):539-544. View summary.

Pajonk, F., Riess, Ok., Sommer, A., and McBride, W. H. N-acetyl-L-cysteine inhibits 26S proteasome perform: implications for results on NF-kappaB activation. Free Radic.Biol Med 3-15-2002;32(6):536-543. View summary.

Pannu, N. and Tonelli, M. Methods to scale back the chance of distinction nephropathy: an evidence-based strategy. Curr Opin.Nephrol.Hypertens. 2006;15(3):285-290. View summary.

Parker, D., White, J. P., Paton, D., and Routledge, P. A. Security of late acetylcysteine remedy in paracetamol poisoning. Hum Exp.Toxicol. 1990;9(1):25-27. View summary.

Parr, G. D. and Huitson, A. Oral Fabrol (oral N-acetyl-cysteine) in continual bronchitis. Br.J.Dis.Chest 1987;81(4):341-348. View summary.

Pate, G. H. Ok, Shamaria, A., Williams, and et al. Intravenous acetylcysteine within the prevention of distinction induced nephropathy following coronary angiography. Circulation 2003;107:IV-445.

Peker, O., Peker, T., Erdogan, D., Ozaydin, M., Kapan, S., Sutcu, R., and Ibrisim, E. Results of intravenous N-acetylcysteine on periprocedural myocardial damage after on-pump coronary artery by-pass grafting. J Cardiovasc.Surg (Torino) 2008;49(4):527-531. View summary.

Peristeris, P., Clark, B. D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., Orencole, S. F., Sironi, M., and Ghezzi, P. N-acetylcysteine and glutathione as inhibitors of tumor necrosis issue manufacturing. Cell Immunol. 1992;140(2):390-399. View summary.

Perry, H. E. and Shannon, M. W. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: outcomes of an open-label, scientific trial. J Pediatr 1998;132(1):149-152. View summary.

Peterson, R. G. and Rumack, B. H. Toxicity of acetaminophen overdose. JACEP. 1978;7(5):202-205. View summary.

Peterson, R. G. and Rumack, B. H. Treating acute acetaminophen poisoning with acetylcysteine. JAMA 5-30-1977;237(22):2406-2407. View summary.

Poder, G., Puskas, J., Kelemen, J., Kiss, A. G., and Cserhati, E. N-Acetylcystein bei chronisch-obstruktiver Bronchitis. Therapiewoche 1984;34:7047-7052.

Poletti, P. A., Saudan, P., Platon, A., Mermillod, B., Sautter, A. M., Vermeulen, B., Sarasin, F. P., Becker, C. D., and Martin, P. Y. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol. 2007;189(3):687-692. View summary.

Powell, S. R. and McCay, P. B. Inhibition of doxorubicin-initiated membrane harm by N-acetylcysteine: doable mediation by a thiol-dependent, cytosolic inhibitor of lipid peroxidation. Toxicol.Appl Pharmacol 1988;96(2):175-184. View summary.

Pratt, S. and Ioannides, C. Mechanism of the protecting motion of n-acetylcysteine and methionine in opposition to paracetamol toxicity within the hamster. Arch Toxicol. 1985;57(3):173-177. View summary.

Prescott, L. F. Remedy of extreme acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med 2-23-1981;141(3 Spec No):386-389. View summary.

Prescott, L. F., Donovan, J. W., Jarvie, D. R., and Proudfoot, A. T. The disposition and kinetics of intravenous N-acetylcysteine in sufferers with paracetamol overdosage. Eur.J Clin Pharmacol 1989;37(5):501-506. View summary.

Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., and Proudfoot, A. T. Intravenous N-acetylcystine: the remedy of selection for paracetamol poisoning. Br Med J 11-3-1979;2(6198):1097-1100. View summary.

Prescott, L. F., Park, J., Ballantyne, A., Adriaenssens, P., and Proudfoot, A. T. Remedy of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 8-27-1977;2(8035):432-434. View summary.

Pulle, D. F., Glass, P., and Dulfano, M. J. A managed examine of the protection and efficacy of acetylcysteine-isoproterenol mixture. Curr Ther Res Clin Exp. 1970;12(8):485-492. View summary.

Rahman, I. and Adcock, I. M. Oxidative stress and redox regulation of lung irritation in COPD. Eur.Respir.J 2006;28(1):219-242. View summary.

Rahman, I. Antioxidant therapies in COPD. Int.J Chron.Impede.Pulmon.Dis. 2006;1(1):15-29. View summary.

Rasmussen, J. B. and Glennow, C. Discount in days of sickness after long-term remedy with N-acetylcysteine controlled-release tablets in sufferers with continual bronchitis. Eur.Respir.J 1988;1(4):351-355. View summary.

Ratjen, F., Wonne, R., Posselt, H. G., Stover, B., Hofmann, D., and Bender, S. W. A double-blind placebo managed trial with oral ambroxol and N-acetylcysteine for mucolytic remedy in cystic fibrosis. Eur.J Pediatr 1985;144(4):374-378. View summary.

Rattan, A. Ok. and Arad, Y. Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC). Atherosclerosis 1998;138(2):319-327. View summary.

Ravez, P., Delwarte, J., Lebert, P., and et al. Quick remedy of respiratory problems with an oral mucolytic agent. Double-blind examine with acetycysteine vs. placebo. Eur J Respir.Dis 1980;61(Suppl 111):76.

REAS, H. W. The impact of N-acetylcysteine on the viscosity of tracheobronchial secretions in cystic fibrosis of the pancreas. J Pediatr 1963;62:31-35. View summary.

REAS, H. W. THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS. J Pediatr 1964;65:542-557. View summary.

Recio-Mayoral, A., Chaparro, M., Prado, B., Cozar, R., Mendez, I., Banerjee, D., Kaski, J. C., Cubero, J., and Cruz, J. M. The reno-protective impact of hydration with sodium bicarbonate plus N-acetylcysteine in sufferers present process emergency percutaneous coronary intervention: the RENO Research. J.Am.Coll.Cardiol. 3-27-2007;49(12):1283-1288. View summary.

Redondo, P., Bandres, E., Solano, T., Okroujnov, I., and Garcia-Foncillas, J. Vascular endothelial progress issue (VEGF) and melanoma. N-acetylcysteine downregulates VEGF manufacturing in vitro. Cytokine 2000;12(4):374-378. View summary.

Reid, M. B. Free radicals and muscle fatigue: Of ROS, canaries, and the IOC. Free Radic.Biol Med 1-15-2008;44(2):169-179. View summary.

Reid, M. B., Stokic, D. S., Koch, S. M., Khawli, F. A., and Leis, A. A. N-acetylcysteine inhibits muscle fatigue in people. J Clin Make investments 1994;94(6):2468-2474. View summary.

Remington, R., Chan, A., Paskavitz, J., and Shea, T. B. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer’s illness: a placebo-controlled pilot examine. Am.J Alzheimers.Dis Different Demen. 2009;24(1):27-33. View summary.

Renke, M., Tylicki, L., Rutkowski, P., Larczynski, W., Aleksandrowicz, E., Lysiak-Szydlowska, W., and Rutkowski, B. The impact of N-acetylcysteine on proteinuria and markers of tubular damage in non-diabetic sufferers with continual kidney illness. A placebo-controlled, randomized, open, cross-over examine. Kidney Blood Press Res 2008;31(6):404-410. View summary.

Reynard, Ok., Riley, A., and Walker, B. E. Respiratory arrest after N-acetylcysteine for paracetamol overdose. Lancet 9-12-1992;340(8820):675. View summary.

Riise, G. C., Larsson, S., Larsson, P., Jeansson, S., and Andersson, B. A. The intrabronchial microbial flora in continual bronchitis sufferers: a goal for N-acetylcysteine remedy? Eur.Respir.J 1994;7(1):94-101. View summary.

Ristikankare, A., Kuitunen, T., Kuitunen, A., Uotila, L., Vento, A., Suojaranta-Ylinen, R., Salmenpera, M., and Poyhia, R. Lack of renoprotective impact of i.v. N-acetylcysteine in sufferers with continual renal failure present process cardiac surgical procedure. Br J Anaesth. 2006;97(5):611-616. View summary.

Rivabene, R., Viora, M., Matarrese, P., Rainaldi, G., D’Ambrosio, A., and Malorni, W. N-acetyl-cysteine enhances cell adhesion properties of epithelial and lymphoid cells. Cell Biol.Int. 1995;19(8):681-686. View summary.

Rizk, A. Y., Bedaiwy, M. A., and Al Inany, H. G. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant sufferers with polycystic ovary syndrome. Fertil.Steril. 2005;83(2):367-370. View summary.

Roberts, R. L., Aroda, V. R., and Ank, B. J. N-acetylcysteine enhances antibody-dependent mobile cytotoxicity in neutrophils and mononuclear cells from wholesome adults and human immunodeficiency virus-infected sufferers. J Infect.Dis. 1995;172(6):1492-1502. View summary.

Rodenstein, D., DeCoster, A., and Gazzaniga, A. Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in sufferers with respiratory problems. Clin Pharmacokinet. 1978;3(3):247-254. View summary.

Rodrigues, A. J., Evora, P. R., Bassetto, S., Alves, L., Jr., Scorzoni, Filho A., Origuela, E. A., and Vicente, W. V. Blood cardioplegia with N-acetylcysteine might cut back coronary endothelial activation and myocardial oxidative stress. Coronary heart Surg Discussion board 2009;12(1):E44-E48. View summary.

Roederer, M., Staal, F. J., Raju, P. A., Ela, S. W., Herzenberg, L. A., and Herzenberg, L. A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl.Acad.Sci U.S.A 1990;87(12):4884-4888. View summary.

Roes, E. M., Raijmakers, M. T., Boo, T. M., Zusterzeel, P. L., Merkus, H. M., Peters, W. H., and Steegers, E. A. Oral N-acetylcysteine administration doesn’t stabilise the method of established extreme preeclampsia. Eur.J Obstet.Gynecol.Reprod.Biol 2006;127(1):61-67. View summary.

Rogers, D. F. and Jeffery, P. Ok. Inhibition by oral N-acetylcysteine of cigarette smoke-induced “bronchitis” within the rat. Exp.Lung Res 1986;10(3):267-283. View summary.

Rogers, D. F., Godfrey, R. W., Majumdar, S., and Jeffery, P. Ok. Oral N-acetylcysteine speeds reversal of cigarette smoke-induced mucous cell hyperplasia within the rat. Exp.Lung Res 1988;14(1):19-35. View summary.

Romano, C., Gargani, G. F., Minicucci, L., and Nantron, M. [Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience]. Minerva Pediatr 2-15-1984;36(3):127-138. View summary.

Rosner, M. H. and Okusa, M. D. Acute kidney damage related to cardiac surgical procedure. Clin J Am Soc Nephrol. 2006;1(1):19-32. View summary.

Rumack, B. H., Peterson, R. C., Koch, G. G., and Amara, I. A. Acetaminophen overdose. 662 circumstances with analysis of oral acetylcysteine remedy. Arch Intern Med 2-23-1981;141(3 Spec No):380-385. View summary.

Rumiris, D., Purwosunu, Y., Wibowo, N., Farina, A., and Sekizawa, A. Decrease price of preeclampsia after antioxidant supplementation in pregnant girls with low antioxidant standing. Hypertens.Being pregnant. 2006;25(3):241-253. View summary.

Sadowska, A. M., Keenoy, B., Vertongen, T., Schippers, G., Radomska-Lesniewska, D., Heytens, E., and De Backer, W. A. Impact of N-acetylcysteine on neutrophil activation markers in wholesome volunteers: in vivo and in vitro examine. Pharmacol Res 2006;53(3):216-225. View summary.

Safarinejad, M. R. and Safarinejad, S. Efficacy of selenium and/or N-acetyl-cysteine for enhancing semen parameters in infertile males: a double-blind, placebo managed, randomized examine. J Urol. 2009;181(2):741-751. View summary.

Salahudeen, A., Poovala, V., Parry, W., Pande, R., Kanji, V., Ansari, N., Morrow, J., and Roberts, J. Cisplatin induces N-acetyl cysteine suppressible F2-isoprostane manufacturing and damage in renal tubular epithelial cells. J.Am.Soc.Nephrol. 1998;9(8):1448-1455. View summary.

Salom, M. G., Ramirez, P., Carbonell, L. F., Lopez, Conesa E., Cartagena, J., Quesada, T., Parrilla, P., and Fenoy, F. J. Protecting impact of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion. Transplantation 5-27-1998;65(10):1315-1321. View summary.

Sanders, Ok. M., Kotowicz, M. A., and Nicholson, G. C. Potential position of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal girls: a pilot examine. Transl.Res 2007;150(4):215. View summary.

Sandhu, C., Belli, A. M., and Oliveira, D. B. The position of N-acetylcysteine within the prevention of contrast-induced nephrotoxicity. Cardiovasc.Intervent.Radiol. 2006;29(3):344-347. View summary.

Sandhu, C., Belli, A. M., and Oliveira, D. B. The position of N-acetylcysteine within the prevention of contrast-induced nephrotoxicity. Cardiovasc.Intervent.Radiol. 2006;29(3):344-347. View summary.

Sandilands, E. A. and Bateman, D. N. Antagonistic reactions related to acetylcysteine. Clin Toxicol.(Phila) 2009;47(2):81-88. View summary.

Santiago, F. M., Bueno, P., Olmedo, C., Muffak-Granero, Ok., Comino, A., Serradilla, M., Mansilla, A., Villar, J. M., Garrote, D., and Ferron, J. A. Impact of N-acetylcysteine administration on intraoperative plasma ranges of interleukin-4 and interleukin-10 in liver transplant recipients. Transplant.Proc 2008;40(9):2978-2980. View summary.

Saricaoglu, F., Dal, D., Salman, A. E., Atay, O. A., Doral, M. N., Salman, M. A., Kilinc, Ok., and Aypar, U. Impact of low-dose N-acetyl-cysteine infusion on tourniquet-induced ischaemia-reperfusion damage in arthroscopic knee surgical procedure. Acta Anaesthesiol.Scand 2005;49(6):847-851. View summary.

Schultz, M. J., Baas, M. C., van der Sluijs, H. P., Stamkot, G. A., and Smit, W. N-acetylcysteine and different preventive measures for contrast-induced nephropathy within the intensive care unit. Curr Med Chem. 2006;13(21):2565-2570. View summary.

Shahin, A. Y., Hassanin, I. M., Ismail, A. M., Kruessel, J. S., and Hirchenhain, J. Impact of oral N-acetyl cysteine on recurrent preterm labor following remedy for bacterial vaginosis. Int J Gynaecol.Obstet. 2009;104(1):44-48. View summary.

Shaikh, Z. A., Vu, T. T., and Zaman, Ok. Oxidative stress as a mechanism of continual cadmium-induced hepatotoxicity and renal toxicity and safety by antioxidants. Toxicol.Appl Pharmacol 2-1-1999;154(3):256-263. View summary.

Sheffner, A. L., Medler, E. M., JACOBS, L. W., and Sarett, H. P. THE IN VITRO REDUCTION IN VISCOSITY OF HUMAN TRACHEOBRONCHIAL SECRETIONS BY ACETYLCYSTEINE. Am Rev.Respir.Dis. 1964;90:721-729. View summary.

Sheikh-Hamad, D., Timmins, Ok., and Jalali, Z. Cisplatin-induced renal toxicity: doable reversal by N-acetylcysteine remedy. J Am Soc Nephrol. 1997;8(10):1640-1644. View summary.

Shohrati, M., Aslani, J., Eshraghi, M., Alaedini, F., and Ghanei, M. Therapeutics impact of N-acetyl cysteine on mustard gasoline uncovered sufferers: evaluating scientific side in sufferers with impaired pulmonary perform take a look at. Respir.Med 2008;102(3):443-448. View summary.

Siriwardena, A. Ok., Mason, J. M., Balachandra, S., Bagul, A., Galloway, S., Formela, L., Hardman, J. G., and Jamdar, S. Randomised, double blind, placebo managed trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) remedy in extreme acute pancreatitis. Intestine 2007;56(10):1439-1444. View summary.

Sisillo, E., Ceriani, R., Bortone, F., Juliano, G., Salvi, L., Veglia, F., Fiorentini, C., and Marenzi, G. N-acetylcysteine for prevention of acute renal failure in sufferers with continual renal insufficiency present process cardiac surgical procedure: a potential, randomized, scientific trial. Crit Care Med 2008;36(1):81-86. View summary.

Sjodin, Ok., Nilsson, E., Hallberg, A., and Tunek, A. Metabolism of N-acetyl-L-cysteine. Some structural necessities for the deacetylation and penalties for the oral bioavailability. Biochem.Pharmacol 11-15-1989;38(22):3981-3985. View summary.

Slavik, M. and Saiers, J. H. Part I scientific examine of acetylcysteine’s stopping ifosfamide-induced hematuria. Semin.Oncol 1983;10(1 Suppl 1):62-65. View summary.

Smilkstein, M. J., Bronstein, A. C., Linden, C., Augenstein, W. L., Kulig, Ok. W., and Rumack, B. H. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine remedy protocol. Ann Emerg.Med 1991;20(10):1058-1063. View summary.

Smilkstein, M. J., Knapp, G. L., Kulig, Ok. W., and Rumack, B. H. Efficacy of oral N-acetylcysteine within the remedy of acetaminophen overdose. Evaluation of the nationwide multicenter examine (1976 to 1985). N.Engl.J Med 12-15-1988;319(24):1557-1562. View summary.

Sochman, J., Vrbska, J., Musilova, B., and Rocek, M. Infarct Measurement Limitation: acute N-acetylcysteine protection (ISLAND trial): preliminary evaluation and report after the primary 30 sufferers. Clin Cardiol. 1996;19(2):94-100. View summary.

Soghier, L. M. and Brion, L. P. Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. Cochrane.Database.Syst.Rev. 2006;(4):CD004869. View summary.

Soltan-Sharifi, M. S., Mojtahedzadeh, M., Najafi, A., Reza, Khajavi M., Reza, Rouini M., Moradi, M., Mohammadirad, A., and Abdollahi, M. Enchancment by N-acetylcysteine of acute respiratory misery syndrome by rising intracellular glutathione, and extracellular thiol molecules and anti-oxidant energy: proof for underlying toxicological mechanisms. Hum Exp.Toxicol. 2007;26(9):697-703. View summary.

Spapen, H., Zhang, H., Demanet, C., Vleminckx, W., Vincent, J. L., and Huyghens, L. Does N-acetyl-L-cysteine affect cytokine response throughout early human septic shock? Chest 1998;113(6):1616-1624. View summary.

Spies, C. D., Reinhart, Ok., Witt, I., Meier-Hellmann, A., Hannemann, L., Bredle, D. L., and Schaffartzik, W. Affect of N-acetylcysteine on oblique indicators of tissue oxygenation in septic shock sufferers: outcomes from a potential, randomized, double-blind examine. Crit Care Med 1994;22(11):1738-1746. View summary.

Spies, C., Giese, C., Meier-Hellmann, A., Specht, M., Hannemann, L., Schaffartzik, W., and Reinhart, Ok. [The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients]. Anaesthesist 1996;45(4):343-350. View summary.

Spiller, H. A., Winter, M. L., Klein-Schwartz, W., and Bangh, S. A. Efficacy of activated charcoal administered greater than 4 hours after acetaminophen overdose. J Emerg.Med 2006;30(1):1-5. View summary.

Sridharan S, Ramamurthy N, and Shyamala CS. In vitro analysis of the anticancer impact of N-acetylcysteine on oral carcinoma cell line. Indian Journal of Pharmacology 2001;33:343-349.

Stacul, F., Adam, A., Becker, C. R., Davidson, C., Lameire, N., McCullough, P. A., and Tumlin, J. Methods to scale back the chance of contrast-induced nephropathy. Am J Cardiol. 9-18-2006;98(6A):59K-77K. View summary.

Stafanger, G. and Koch, C. N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa an infection: scientific rating, spirometry and ciliary motility. Eur.Respir.J 1989;2(3):234-237. View summary.

Stafanger, G., Garne, S., Howitz, P., Morkassel, E., and Koch, C. The scientific impact and the impact on the ciliary motility of oral N-acetylcysteine in sufferers with cystic fibrosis and first ciliary dyskinesia. Eur.Respir.J 1988;1(2):161-167. View summary.

STAMM, S. J. and DOCTER, J. CLINICAL EVALUATION OF ACETYLCYSTEINE AS A MUCOLYTIC AGENT IN CYSTIC FIBROSIS. Dis.Chest 1965;47:414-420. View summary.

Stavem, Ok. [Anaphylactic reaction to N-acetylcysteine after poisoning with paracetamol]. Tidsskr.Nor Laegeforen. 5-30-1997;117(14):2038-2039. View summary.

Steil, E. and Niessen, Ok. H. Expiratory ventilatory capability measurements in kids with cystic fibrosis handled by oral acetylcysteine. Eur.J Respir.Dis.Suppl 1980;111:132-133. View summary.

Stenstrom, D. A., Muldoon, L. L., Armijo-Medina, H., Watnick, S., Doolittle, N. D., Kaufman, J. A., Peterson, D. R., Bubalo, J., and Neuwelt, E. A. N-acetylcysteine use to forestall distinction medium-induced nephropathy: untimely part III trials. J Vasc.Interv.Radiol. 2008;19(3):309-318. View summary.

Stephan, U. and Sitzmann, F. C. [On a new possibility of treating pulmonary complications of mucoviscidosis]. Dtsch.Med Wochenschr. 12-3-1965;90(49):2192-2197. View summary.

Stephan, U., Bowing, B., Goering, U., Wiesemann, H. G., Reinhardt, M., Hirche, H., and Brandt, H. Acetylcysteine within the oral mucolytic remedy of cystic fibrosis. Eur.J Respir.Dis.Suppl 1980;111:127-131. View summary.

Stewart, S., Prince, M., Bassendine, M., Hudson, M., James, O., Jones, D., File, C., and Day, C. P. A randomized trial of antioxidant remedy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol. 2007;47(2):277-283. View summary.

Stey, C., Steurer, J., Bachmann, S., Medici, T. C., and Tramer, M. R. The impact of oral N-acetylcysteine in continual bronchitis: a quantitative systematic evaluate. Eur.Respir.J 2000;16(2):253-262. View summary.

Sucu, N., Cinel, I., Unlu, A., Aytacoglu, B., Tamer, L., Kocak, Z., Karaca, Ok., Gul, A., Dikmengil, M., Atik, U., and Oral, U. N-acetylcysteine for stopping pump-induced oxidoinflammatory response throughout cardiopulmonary bypass. Surg At present 2004;34(3):237-242. View summary.

Sunman, W., Hughes, A. D., and Sever, P. S. Anaphylactoid response to intravenous acetylcysteine. Lancet 5-16-1992;339(8803):1231-1232. View summary.

Suter, P. M., Domenighetti, G., Schaller, M. D., Laverriere, M. C., Ritz, R., and Perret, C. N-acetylcysteine enhances restoration from acute lung damage in man. A randomized, double-blind, placebo-controlled scientific examine. Chest 1994;105(1):190-194. View summary.

Sutherland, E. R., Crapo, J. D., and Bowler, R. P. N-acetylcysteine and exacerbations of continual obstructive pulmonary illness. COPD. 2006;3(4):195-202. View summary.

Tandon, S. Ok., Prasad, S., and Singh, S. Chelation in metallic intoxication: affect of cysteine or N-acetyl cysteine on the efficacy of two,3-dimercaptopropane-1-sulphonate within the remedy of cadmium toxicity. J Appl Toxicol 2002;22(1):67-71. View summary.

Tariq, M., Morais, C., Sobki, S., Al, Sulaiman M., and Al, Khader A. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol.Dial.Transplant. 1999;14(4):923-929. View summary.

Tattersall, A. B., Bridgman, Ok. M., and Huitson, A. Acetylcysteine (Fabrol) in continual bronchitis–a examine basically follow. J Int Med Res 1983;11(5):279-284. View summary.

Tattersall, A. B., Bridgman, Ok. M., and Huitson, A. Irish basic follow examine of acetylcysteine (Fabrol) in continual bronchitis. J Int Med Res 1984;12(2):96-101. View summary.

Tecklin, J. S. and Holsclaw, D. S., Jr. Bronchial drainage with aerosol drugs in cystic fibrosis. Phys.Ther 1976;56(9):999-1003. View summary.

ten Dam, M. A. and Wetzels, J. F. Toxicity of distinction media: an replace. Neth.J Med 2008;66(10):416-422. View summary.

Thaha, M., Yogiantoro, M., and Tomino, Y. Intravenous N-acetylcysteine throughout haemodialysis reduces the plasma focus of homocysteine in sufferers with end-stage renal illness. Clin Drug Investig. 2006;26(4):195-202. View summary.

Thanopoulou, E., Baltayiannis, N., and Lykogianni, V. Dietary elements relating to lung most cancers chemoprevention. J BUON. 2006;11(1):7-20. View summary.

Tirouvanziam, R., Conrad, C. Ok., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., and Herzenberg, L. A. Excessive-dose oral N-acetylcysteine, a glutathione prodrug, modulates irritation in cystic fibrosis. Proc Natl.Acad.Sci U.S.A 3-21-2006;103(12):4628-4633. View summary.

Tolar, J., Orchard, P. J., Bjoraker, Ok. J., Ziegler, R. S., Shapiro, E. G., and Charnas, L. N-acetyl-L-cysteine improves end result of superior cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007;39(4):211-215. View summary.

Tolley, D. A. and Castro, J. E. Cyclophosphamide-induced cystitis of the urinary bladder of rats and its remedy. Proc R.Soc Med 1975;68(3):169-170. View summary.

Tossios, P., Bloch, W., Huebner, A., Raji, M. R., Dodos, F., Klass, O., Suedkamp, M., Kasper, S. M., Hellmich, M., and Mehlhorn, U. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in sufferers present process cardiac surgical procedure: outcomes of a randomized, double-blind, placebo-controlled scientific trial. J Thorac.Cardiovasc.Surg 2003;126(5):1513-1520. View summary.

Tozawa, Ok., Okamoto, T., Hayashi, Y., Sasaki, S., Kawai, N., and Kohri, Ok. N-acetyl-L-cysteine enhances chemotherapeutic impact on prostate most cancers cells. Urol.Res 2002;30(1):53-58. View summary.

Treitinger, A., Spada, C., Masokawa, I. Y., Verdi, J. C., Van Der Sander, Silveira M., Luis, M. C., Reis, M., Ferreira, S. I., and Abdalla, D. S. Impact of N-acetyl-L-cysteine on lymphocyte apoptosis, lymphocyte viability, TNF-alpha and IL-8 in HIV-infected sufferers present process anti-retroviral remedy. Braz.J Infect.Dis 2004;8(5):363-371. View summary.

Unverferth, B. J., Magorien, R. D., Balcerzak, S. P., Leier, C. V., and Unverferth, D. V. Early adjustments in human myocardial nuclei after doxorubicin. Most cancers 7-15-1983;52(2):215-221. View summary.

City, T., Akerlund, B., Jarstrand, C., and Lindeke, B. Neutrophil perform and glutathione-peroxidase (GSH-px) exercise in wholesome people after remedy with N-acetyl-L-cysteine. Biomed.Pharmacother. 1997;51(9):388-390. View summary.

Uys, J. D. and LaLumiere, R. T. Glutamate: the brand new frontier in pharmacotherapy for cocaine dependancy. CNS.Neurol.Disord.Drug Targets. 2008;7(5):482-491. View summary.

Vale, J. A. and Buckley, B. M. Bronchial asthma related to N-acetylcysteine infusion and paracetamol poisoning. Br Med J (Clin Res Ed) 10-22-1983;287(6400):1223. View summary.

Vale, J. A. and Wheeler, D. C. Anaphylactoid response to acetylcysteine. Lancet 10-30-1982;2(8305):988. View summary.

Cetylev (acetylcysteine) package deal insert. Atlanta, GA: Arbor Prescription drugs LLC; January 2016.

Chamberlain JM, Gorman RL, Oderda GM, Klein-Schwartz W, Klein BL. Use of activated charcoal in a simulated poisoning with acetaminophen: a brand new loading dose for N-acetylcysteine? Ann Emerg Med. 1993;22(9):1398-402. View summary.

Christensen PM, Bangsbo J. N-Acetyl cysteine doesn’t enhance repeated intense endurance biking efficiency of well-trained cyclists. Eur J Appl Physiol 2019;119(6):1419-29. View summary.

Chyka PA, Butler AY, Holliman BJ, Herman MI. Utility of acetylcysteine in treating poisonings and antagonistic drug reactions. Drug Saf 2000;22:123-48. View summary.

Costa DLC, Diniz JB, Requena G, et al. Randomized double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive dysfunction. J Clin Psychiatry. 2017 Jul;78(7):e799-e773. View summary.

Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American School of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr;147(4):894-942. View summary.

de Alencar JCG, Moreira CL, Müller AD, et al. Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Remedy of Extreme Acute Respiratory Syndrome Brought on by Coronavirus Illness 2019 (COVID-19). Clin Infect Dis. 2021;72(11):e736-e741. View summary.

De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and enchancment of cell-mediated immunity with long-term N-acetylcysteine remedy. Eur Respir J 1997;10:1535-41. View summary.

De Rosa SC, Zaretsky MD, Dubs JG, et al. N-acetylcysteine replenishes glutathione in HIV an infection. Eur J Clin Make investments 2000;30:915-29.

Dean OM, Bush AI, Copolov DL, et al. Results of N-acetyl cysteine on cognitive perform in bipolar dysfunction. Psychiatry Clin Neurosci 2012;66(6):514-7. View summary.

Dean OM, Grey KM, Villagonzalo KA, et al. A randomized, double-blind, placebo-controlled trial of a hard and fast dose of N-acetylcysteine in kids with autistic dysfunction. Aust N Z J Psychiatry. 2017 Mar;51(3):241-49. View summary.

Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H. Potentiation of the antimalarial motion of chloroquine in rodent malaria by medicine recognized to scale back mobile glutathione ranges. Biochem Pharmacol. 2003;66(5):809-17. View summary.

Devi N, Boya C, Chhabra M, Bansal D. N-acetyl-cysteine as adjuvant remedy in feminine infertility: a scientific evaluate and meta-analysis. J Primary Clin Physiol Pharmacol. 2020;32(5):899-910. View summary.

Dickey DT, Muldoon LL, Kraemer DF, Neuwelt EA. Safety in opposition to cisplatin-induced ototoxicity by N-acetylcysteine in a rat mannequin. Hear Res 2004;193:25-30. View summary.

Doosti A, Lotfi Y, Moossavi A, Bakhshi E, Talasaz AH, Hoorzad A. Comparability of the results of N-acetyl-cysteine and ginseng in prevention of noise induced listening to loss in male textile employees. Noise Well being 2014;16(71):223-7. View summary.

Dresdale AR, Barr LH, Bonow RO, et al. Potential randomized examine of the position of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy. Am J Clin Oncol 1982;5:657-63. View summary.

Duan M, Qiu J, Laurell G, et al, Dose and time-dependent safety of the antioxidant N-L-acetycysteine in opposition to impulse noise trauma. Hear Res 2004;192:1-9. View summary.

Dunning JR, Trella JD, Osterhoudt KC. A Novel Oral Formulation of N-Acetylcysteine. Pediatr Emerg Care. 2016 Sep;32(9):652. View summary.

Ekins BR, Ford DC, Thompson MI, et al. The impact of activated charcoal on N-acetylcysteine absorption in regular topics. Am J Emerg Med. 1987;5(6):483-7. View summary.

El Sharkwy IA, Abd El Aziz WM. Randomized managed trial of N-acetylcysteine versus l-carnitine amongst girls with clomiphene-citrate-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2019;147(1):59-64. doi: 10.1002/ijgo.12902. View summary.

Ellegaard PK, Licht RW, Nielsen RE, et al. The efficacy of adjunctive N-acetylcysteine in acute bipolar melancholy: A randomized placebo-controlled examine. J Have an effect on Disord. 2019;245:1043-1051. View summary.

Eroglu N, Erduran E, Reis GP, Bahadir A. Therapeutic impact of N-acetylcysteine on chemotherapy-induced liver damage. Ir J Med Sci. 2020. View summary.

Estensen RD, Levy M, Klopp SJ, et al. N-acetylcysteine suppression of the proliferative index within the colon of sufferers with earlier adenomatous colonic polyps. Most cancers Lett 1999;147:109-14. View summary.

Faverio P, Rebora P, Rossi E, et al. Impression of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: outcomes from a big cohort examine. ERJ Open Res 2021;8(1):00542-2021. View summary.

Fontes LES, Martimbianco ALC, Zanin C, Riera R. N-acetylcysteine as an adjuvant remedy for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2019;2:CD012357. View summary.

Fowdar Ok, Chen H, He Z, et al. The impact of N-acetylcysteine on exacerbations of continual obstructive pulmonary illness: a meta-analysis and systematic evaluate. Coronary heart Lung. 2017 Mar-Apr;46(2):120-128. View summary.

Ghanizadeh A, Moghimi-Sarani E. A randomized double blind placebo managed scientific trial of N-acetylcysteine added to risperidone for treating autistic problems. BMC Psychiatry 2013;13:196. View summary.

Ghio S, de Servi S, Perotti R, et al. Completely different susceptibility to the event of nitroglycerin tolerance within the arterial and venous circulation in humans- results of N-acetylcysteine administration. Circulation 1992;86:798-802. View summary.

Giacoppo D, Gargiulo G, Buccheri S, et al. Preventive methods for contrast-induced acute kidney damage in sufferers present process percutaneous coronary procedures: proof from a hierarchical Bayesian community meta-analysis of 124 trials and 28,240 sufferers. Circ Cardiovasc Interv. 2017 Might;10(5). View summary.

Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant remedy. Respir Med 1998;92:609-23. View summary.

International Initiative for Persistent Obstructive Lung Illness (GOLD). GOLD 2017 international technique for the analysis, administration, and prevention of continual obstructive pulmonary illness, 2017 report. Accessed June 24, 2018.

Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. Efficacy of oral long-term N-acetylcysteine in continual bronchopulmonary illness: a meta-analysis of revealed double-blind, placebo-controlled scientific trials. Clin Ther 2000;22:209-21. View summary.

Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, within the remedy of trichotillomania: a double-blind, placebo-controlled examine. Arch Gen Psychiatry 2009;66:756-63. View summary.

Grey KM, Carpenter MJ, Baker NL, et al. A double-blind randomized managed trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169(8):805-12. View summary.

Grey KM, Sonne SC, McClure EA, et al. A randomized placebo-controlled trial of N-acetylcysteine for hashish use dysfunction in adults. Drug Alcohol Rely. 2017;177:249-257. View summary.

Grendar J, Ouellet JF, McKay A, et al. Impact of N-acetylcysteine on liver restoration after resection: A randomized scientific trial. J Surg Oncol. 2016;114(4):446-50. View summary.

Gu WJ, Wu ZJ, Wang PF, et al. N-acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgical procedure: a meta-analysis of eight randomized managed trials. BMC Cardiovascular Issues 2012;12:10. View summary.

Haase M, Haase-Fielitz A, Ratnaike S, et al. N-Acetylcysteine doesn’t artifactually decrease plasma creatinine focus. Nephrol Dial Transplant. 2008;23(5):1581-7. View summary.

Halboub E, Alkadasi B, Alakhali M, et al. N-acetylcysteine versus chlorhexidine in remedy of aphthous ulcers: a preliminary scientific trial. J Dermatolog Deal with. 2019:1-5. View summary.

Hardan AY, Fung LK, Libove RA, et al. A randomized managed pilot trial of oral N-acetylcysteine in kids with autism. Biol Psychiatry 2012;71(11):956-61. View summary.

He G, Li Q, Li W, Wang L, Yang J, Zeng F. N-Acetylcysteine for Stopping of Acute Kidney Harm in Persistent Kidney Illness Sufferers Present process Cardiac Surgical procedure: A Metaanalysis. Coronary heart Surg Discussion board. 2018;21(6):E513-E521. View summary.

Hogan JC, Lewis MJ, Henderson AH. Persistent administration of N-acetylcysteine fails to forestall nitrate tolerance in sufferers with steady angina pectoris. Br J Clin Pharmacol 1990;30:573-7. View summary.

Hogan JC, Lewis MJ, Henderson AH. N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in wholesome volunteers. Br J Clin Pharmacol 1989;28:421-6. View summary.

Holoye PY, Duelge J, Hansen RM, et al. Prophylaxis of Ifosamide toxicity with oral acetylcysteine. Semin Oncol 1983;10:66-71. View summary.

Holt S, Goodier D, Marley R, et al. Enchancment in renal perform in hepatorenal syndrome with N-acetylcysteine. Lancet 1999;353:294-5. View summary.

Horowitz JD, Henry CA, Syrjanen ML, et al. Nitroglycerine/N-acetylcysteine within the administration of unstable angina pectoris. Eur Coronary heart J 1988;9:95-100. View summary.

Horowitz RS, Dart RC, Jarvie DR, et al. Placental switch of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol 1997;35:447-51. View summary.

Hurd RW, Wilder BJ, Helveston WR, et al. Remedy of 4 siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg kind with N-acetylcysteine. Neurology 1996;47:1264-8. View summary.

Iversen HK. N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther 1992;52:125-33. View summary.

Jannatifar R, Parivar Ok, Roodbari NH, Nasr-Esfahani MH. Results of N-acetyl-cysteine supplementation on sperm high quality, chromatin integrity and degree of oxidative stress in infertile males. Reprod Biol Endocrinol. 2019;17(1):24. View summary.

Javaherforooshzadeh F, Shaker Z, Rashidi M, Akhondzadeh R, Hayati F. The impact of N-acetyl cysteine injection on renal perform after coronary artery bypass graft surgical procedure: a randomized double blind scientific trial. J Cardiothorac Surg. 2021;16(1):161. View summary.

Jenkins DD, Wiest DB, Mulvihill DM, et al. Fetal and neonatal results of N-acetylcysteine when used for neuroprotection in maternal chorioamnionitis. J Pediatr. 2016 Jan;168:67-76.e6. View summary.

Jepsen S, Hansen AB. The affect of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in wholesome topics. Scand J Clin Lab Make investments 1994;54:543-7. View summary.

Johnson Ok, McEvoy CE, Naqvi S, et al. Excessive-dose oral N-acetylcysteine fails to enhance respiratory well being standing in sufferers with continual obstructive pulmonary illness and continual bronchitis: a randomized, placebo-controlled trial. Int J Chron Impede Pulmon Dis. 2016 Apr 21;11:799-807. View summary.

Kakaei F, Fasihi M, Hashemzadeh S, et al. Impact of N-acetylcysteine on liver and kidney perform exams after surgical bypass in obstructive jaundice: A randomized managed trial. Asian J Surg. 2020;43(1):322-329. View summary.

Kelly GS. Scientific purposes of N-acetylcysteine. Altern Med Rev 1998;3:114-27. View summary.

Khatami MR, Nikravan N, Salarifar M, et al. Comparability of oral and intravenous N-acetyl cysteine in stopping distinction nephropathy. Indian J Nephrol. 2020;30(6):403-8. View summary.

Kopke RD, Jackson RL, Coleman JKM, et al. NAC for noise: From the bench prime to the clinic. Hear Res 2007;226:114-25. View summary.

Kopke RD, Weisskopf PA, Boone JL, et al. Discount of noise-induced listening to loss utilizing L-NAC and salicylate within the chinchilla. Hear Res 2000;149:138-146. View summary.

Kranzer Ok, Elamin WF, Cox H, Seddon JA, Ford N, Drobniewski F. A scientific evaluate and meta-analysis of the efficacy and security of N-acetylcysteine in stopping aminoglycoside-induced ototoxicity: implications for the remedy of multidrug-resistant TB. Thorax. 2015 Nov;70(11):1070-7. View summary.

Kroon AA, Demacker PN, Stalenhoef AF. N-acetylcysteine and serum concentrations of lipoprotein(a). J Intern Med 1991;230:519-26. View summary.

Lai ZW, Hanczko R, Bonilla E, et al. N-acetylcysteine reduces illness exercise by blocking mammalian goal rapamycin in T cells from systemic lupus erythematosus sufferers: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2012;64(9):2937-46. View summary.

Lee JV, Engel C, Tay S, et al. Impression of N-Acetyl-Cysteine on Ischemic Stumps Following Main Decrease Extremity Amputation: A Pilot Randomized Scientific Trial. Ann Surg 2022. View summary.

Lete I, Mendoza N, de la Viuda E, Carmona F. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain within the remedy of endometriosis-associated pelvic ache: LEAP examine. Eur J Obstet Gynecol Reprod Biol. 2018;228:221-224. View summary.

Li F, Welling MC, Johnson JA, et al. N-acetylcysteine for pediatric obsessive-compulsive dysfunction: A small pilot examine. J Little one Adolesc Psychopharmacol. 2020;30(1):32-37. View summary.

Loehrer PJ Sr, Birch R, Kramer BS, et al. Ifosfamide plus N-acetylcysteine within the remedy of small cell and non-small cell carcinoma of the lung: a Southeastern Most cancers Research Group Trial. Most cancers Deal with Rep 1986;70:919-20.

Loehrer PJ, Williams SD, Einhorn LH. N-acetylcysteine and ifosfamide within the remedy of unresectable pancreatic adenocarcinoma and refractory testicular most cancers. Semin Oncol 1983;10:72-5.

Lorito G, Giordano P, Prosser S, et al. Noise-induced listening to loss: a examine on the pharmacological safety within the Sprague Dawley rat with N-acetyl-cysteine. Acta Otorhinolaryngol Ital 2006;26:133-9. View summary.

Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Make investments. 1985;76(2):703-8. View summary.

Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, managed trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52:559-64. View summary.

Magalhaes PV, Dean OM, Bush AI, et al. N-acetyl cysteine add-on remedy for bipolar II dysfunction: a subgroup evaluation of randomized placebo-controlled trial. J Have an effect on Disord 2011;129(1-3):317-20. View summary.

Marchetti G, Lodola E, Licciardello L, Colombo A. Use of N-acetylcysteine within the administration of coronary artery ailments. Cardiologia 1999;44:633-7. View summary.

Marchiori D, Zanello PP. Efficacy of N-acetylcysteine, D-mannose and Morinda citrifolia to deal with recurrent cystitis in breast most cancers survivals. In Vivo. 2017 Sep-Oct;31(5):931-936. View summary.

Mei M, Zhao HW, Pan QG, et al. Efficacy of N-Acetylcysteine in Stopping Acute Kidney Harm After Cardiac Surgical procedure: A Meta-Evaluation Research. J Make investments Surg. 2018;31(1):14-23. View summary.

Michailidis Y, Karagounis LG, Terzis G, et al. Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and restoration after intense eccentric train. Am J Clin Nutr 2013;98(1):233-45. View summary.

Molnar Z, Shearer E, Lowe D. N-Acetylcysteine remedy to forestall the development of multisystem organ failure: a potential, randomized, placebo-controlled examine. Crit Care Med 1999;27:1100-4. View summary.

Monti DA, Zabrecky G, Leist TP, et al. N-acetyl cysteine administration is related to elevated cerebral glucose metabolism in sufferers with a number of sclerosis: An exploratory examine. Entrance Neurol. 2020;11:88. View summary.

Morgan LR, Donley PJ, Harrison EF, Hunter HL. The management of ifosfamide-induced hematuria with N-acetylcysteine in sufferers with superior carcinoma of the lung. Semin Oncol 1982;9:71-4.

Morgan LR, Holdiness MR, Gillen LE. N-acetylcysteine: its bioavailability and interplay with ifosfamide metabolites. Semin Oncol 1983;10:56-61.

Morini M, Cai T, Aluigi MG, et al. The position of the thiol N-acetylcysteine within the prevention of tumor invasion and angiogenesis. Int J Biol Markers 1999;14:268-71. View summary.

Munshi NC, Loehrer PJ Sr, Williams SD, et al. Comparability of N-acetylcysteine and mesna as uroprotectors with ifosfamide mixture chemotherapy in refractory germ cell tumors. Make investments New Medicine 1992;10:159-163.. View summary.

Murch SJ, Simmons CB, Saxena PK. Melatonin in feverfew and different medicinal crops. Lancet 1997;350:1598-9. View summary.

North DS, Peterson RG, Krenzelok EP. Impact of activated charcoal administration on acetylcysteine serum ranges in people. Am J Hosp Pharm. 1981;38(7):1022-4. View summary.

Norton EW. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1460. View summary.

Oldemeyer JB, Biddle WP, Wurdeman RL, et al. Acetylcysteine within the prevention of contrast-induced nephropathy after coronary angiography. Am Coronary heart J 2003;146:E23. . View summary.

Oliveira CP, Cotrim HP, Stefano JT, Siqueira ACG, Salgado ALA, Parise ER. N-Acetylcysteine and/or ursodeoxycholic acid related to metformin in non-alcoholic steatohepatitis: an open-label multicenter randomized managed trial. Arq Gastroenterol 2019;56(2):184-90. View summary.

Oner G, Muderris II. Scientific, endocrine and metabolic results of metformin vs N-acetyl-cysteine in girls with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011;159(1):127-31. View summary.

Pannu, N., Wiebe, N., and Tonelli, M. Prophylaxis methods for contrast-induced nephropathy. JAMA 2006;295(23):2765-2779. View summary.

Papi A, Di Stefano AFD, Radicioni M. Pharmacokinetics and security of single and a number of doses of oral N-acetylcysteine in wholesome Chinese language and Caucasian volunteers: an open-label, part I scientific examine. Adv Ther. 2021;38(1):468-78. View summary.

Pasupathy S, Tavella R, Grover S, et al. Early use of N-acetylcysteine with nitrate remedy in sufferers present process main percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct measurement (the NACIAM Trial [N-acetylcysteine in acute myocardial infarction]). Circulation. 2017 Sept 5;136(10):894-903. View summary.

Paydary Ok, Akamaloo A, Ahmadipour A, Pishgar F, Emamzadehfard S, Akhondzadeh S. N-acetylcysteine augmentation remedy for moderate-to-severe obsessive-compulsive dysfunction: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2016 Apr;41(2):214-9. View summary.

Pela R, Calcagni AM, Subiaco S, et al. N-acetylcysteine reduces the exacerbation price in sufferers with reasonable to extreme COPD. Respiration 1999;66:495-500.. View summary.

Product info for acetylcysteine inhalant. American Regent, Inc., Shirley, NY. Might 2014.

Qi Q, Ailiyaer Y, Liu R, et al. Impact of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized managed trial. Respir Res 2019;20(1):73. View summary.

Rafiee B, Bagher Tabei SM. The impact of N-acetyl cysteine consumption on males with irregular sperm parameters attributable to optimistic historical past of COVID-19 within the final three months. Arch Ital Urol Androl 2021;93(4):465-467. View summary.

Renzi FP, Donovan JW, Martin TG, Morgan L, Harrison EF. Concomitant use of activated charcoal and N-acetylcysteine. Ann Emerg Med. 1985;14(6):568-72. View summary.

Rogliani P, Calzetta L, Cavalli F, Matera MG, Cazzola M. Pirfenidone, nintedanib and N-acetylcysteine for the remedy of idiopathic pulmonary fibrosis: A scientific evaluate and meta-analysis. Pulm Pharmacol Ther. 2016;40:95-103. View summary.

Ruiz FJ, Salom MG, Inglés AC, et al. N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs. Am J Physiol. 1994;267(3 Pt 2):R767-72. View summary.

Sacchinelli A, Venturella R, Lico D, et al. The efficacy of inositol and N-acetyl cysteine administration (Ovaric HP) in enhancing the ovarian perform in infertile girls with PCOS with or with out insulin resistance. Obstet Gynecol Int 2014;2014:141020. View summary.

Salehpour S, Sene AA, Saharkhiz N, et al. N-Acetylcysteine as an adjuvant to clomiphene citrate for profitable induction of ovulation in infertile sufferers with polycystic ovary syndrome. J Obstet Gynaecol Res 2012;38(9):1182-6. View summary.

Sarris J, Byrne G, Citadel D, et al. N-acetyl cysteine (NAC) augmentation within the remedy of obsessive-compulsive dysfunction: A part III, 20-week, double-blind, randomized, placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2022;117:110550. View summary.

Schmidl D, Werkmeister R, Kaya S, et al. A Managed, Randomized Double-Blind Research to Consider the Security and Efficacy of Chitosan-N-Acetylcysteine for the Remedy of Dry Eye Syndrome. J Ocul Pharmacol Ther. 2017;33(5):375-382. View summary.

Sekharam M, Trotti A, Cunnick JM, Wu J. Suppression of fibroblast cell cycle development in G1 part by N-acetylcysteine. Toxicol Appl Pharmacol 1998;149:210-6. View summary.

Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects in opposition to acute renal harm in sufferers with irregular renal perform present process a coronary process. J Am Coll Cardiol 2002;40:1383-8.. View summary.

Sio TT, Blanchard MJ, Novotny PJ, et al. N-acetylcysteine rinse for thick secretion and mucositis of head and neck chemoradiotherapy (Alliance MC13C2): A double-blind randomized scientific trial. Mayo Clin Proc. 2019;94(9):1814-1824. View summary.

Slattery KM, Dascombe B, Wallace LK, et al. Impact of N-acetylcysteine on biking efficiency after intensified coaching. Med Sci Sports activities Exerc 2014;46(6):1114-23. View summary.

Spiller HA, Krenzelok EP, Grande GA, et al. A potential analysis of the impact of activated charcoal earlier than oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994;23:519-23. View summary.

Su X, Xie X, Liu L, et al. Comparative effectiveness of 12 remedy methods for stopping contrast-induced acute kidney damage: a scientific evaluate and Bayesian community meta-analysis. Am J Kidney Dis. 2017 Jan;69(1):69-77. View summary.

Taher A, Lashgari M, Sedighi L, et al. A pilot examine on intravenous N-Acetylcysteine remedy in sufferers with mild-to-moderate COVID19-associated acute respiratory misery syndrome. Pharmacol Rep. 2021;1-10. View summary.

Tam J, Nash EF, Ratjen F, et al. Nebulized and oral thiol derivatives for pulmonary illness in cystic fibrosis. Cochrane Database Syst Rev. 2013;7:CD007168. View summary.

Tenenbein PK, Sitar DS, Tenenbein M. Interplay between N-acetylcysteine and activated charcoal: implications for the remedy of acetaminophen poisoning. Pharmacotherapy 2001;21:1331-6. View summary.

Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal perform by acetylcysteine. N Engl J Med 2000;343:180-4. View summary.

Tepel M, van der Giet M, Statz M, et al. The antioxidant acetylcysteine reduces cardiovascular occasions in sufferers with end-stage renal failure: a randomized, managed trial. Circulation 2003;107:992-5.. View summary.

Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a scientific evaluate and meta-analysis of randomized managed scientific trials. Obstet Gynecol Int. 2015;2015:817849.

Tomko RL, Baker NL, Hood CO, et al. Depressive signs and hashish use in a placebo-controlled trial of N-Acetylcysteine for grownup hashish use dysfunction. Psychopharmacology (Berl). 2020;237(2):479-490. View summary.

Tomko RL, Gilmore AK, Grey KM. The position of depressive signs in remedy of adolescent hashish use dysfunction with N-Acetylcysteine. Addict Behav. 2018;85:26-30. View summary.

U.S. Meals and Drug Administration. Accredited drug merchandise with therapeutic equivalence analysis, thirty sixth version. Accessed 27 December 2016. Obtainable at:

Unverferth DV, Jagadeesh JM, Unverferth Bj, et al. Try to forestall doxorubicin-induced acute human myocardial morphologic harm with acetylcysteine. J Natl Most cancers Inst 1983;71:917-20. View summary.

Vadoud-Seyedi J, de Dobbeleer G, Simonart T. Remedy of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two circumstances. Br J Dermatol 2000;142:580-1. View summary.

van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in sufferers with head and neck most cancers or lung most cancers. For the European Group for Analysis and Remedy of Most cancers Head and Neck and Lung Most cancers Cooperative Teams. J Natl Most cancers Inst 2000;92:977-86. View summary.

van Zandwijk N. N-acetylcysteine for lung most cancers prevention. Chest 1995;107:1437-41. View summary.

Wang W, Zhang Y, Liu Y, Xu L, Shi D. Extreme chest ache attributable to N-acetylcysteine-induced esophagitis. Case Rep Med. 2019;2019:8057259. View summary.

Warning Letter. LES Labs. U.S. Meals & Drug Administration. Up to date July 29, 2020. Accessed Might 1, 2021.

Wei J, Pang CS, Han J, Yan H. Impact of orally administered N-acetylcysteine on continual bronchitis: A meta-analysis. Adv Ther. 2019;36(12):3356-3367. View summary.

Weinbroum AA, Rudick V, Ben-Abraham R, Karchevski E. N-acetyl-L-cysteine for stopping lung reperfusion damage after liver ischemia-reperfusion: a doable twin protecting mechanism in a dose-response examine. Transplantation 2000;69:853-9. View summary.

Wiklund O, Fager G, Andersson A, et al. N-acetylcysteine remedy lowers plasma homocysteine however not serum lipoprotein(a) ranges. Atherosclerosis 1996;119:99-106. View summary.

Williamson J, Davidson DF, Boag DE. Contamination of a specimen with N-acetyl cysteine infusion: a reason for spurious ketonaemia and hyperglycaemia. Ann Clin Biochem. 1989;26 ( Pt 2):207. View summary.

Yolland CO, Hanratty D, Neill E, et al. Meta-analysis of randomised managed trials with N-acetylcysteine within the remedy of schizophrenia. Aust N Z J Psychiatry. 2020;54(5):453-466. View summary.

Yoon H, Lee DH, Jang ES, et al. Results of N-acetylcysteine on first-line sequential remedy for Helicobacter pylori an infection: a randomized managed pilot trial. Intestine Liver. 2016 Jul 15;10(4):520-5. View summary.

Younger DS. Results of Medicine on Scientific Laboratory Checks 4th ed. Washington: AACC Press, 1995.